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Abstract 
Protein homeostasis describes the cellular balance between protein synthesis, function 
and degradation. The stress inducible co-chaperone BAG3 is a key factor in proteostasis 
in particular under mechanical stress. In cooperation with the actin binding protein 
Synaptopodin 2 (SYNPO2), BAG3 is a central element of filamin (an actin crosslinking 
protein) homeostasis in muscle cells. Here BAG3 is involved in the degradation of 
defective filamin via chaperone assisted selective autophagy (CASA) as well as in the 
induction of filamin transcription via the Hippo pathway. SYNPO2 can directly bind to the 
WW-domain of BAG3 and is enabled to recruit complexes mediating the formation of 
autophagosomes via its N-terminal PDZ-domain. 
SYNPO2 belongs to the SYNPO family of actin binding proteins. Four isoforms of 
SYNPO2 exist of which three contain an N-terminal PDZ-domain, whereas all four 
isoforms have a centrally located proline-rich motif (PPXY-motif). SYNPO2 was identified 
to interact with BAG3 via its PPXY-motif in a peptde screen for novel binding partners of 
the BAG3 WW-domain. Another SYNPO family member, Synaptopodin (SYNPO), was 
also identified in this peptide screen. SYNPO has three isoforms of which all contain two 
subsequent PPXY-motifs. Furthermore, SYNPO has been described to interact with the 
PDZ-domain containing protein MAGI-1 (Membrane Associated Guanylate Kinase 
Inverted 1). 
In this work SYNPO could be confirmed as novel BAG3 binding partner. Because 
SYNPO2 is not expressed ubiquitously in all cell types, it should be clarified whether 
SYNPO, together with BAG3, is similarly involved in autophagic protein degradation as 
shown for SYNPO2. In HeLa cells, which do not express SYNPO2, SYNPO turnover was 
monitored in the context of inhibition of the proteasome or autophagy. In contrast to 
SYNPO2, which is rapidly degraded via autophagy upon inhibition of the proteasome or 
mechanical stress, SYNPO protein levels remained stable upon inhibiton of the 
proteasome or autophagy. Furthermore, no association of SYNPO with autophagic 
marker proteins such as LC3 or p62 could be observed in HeLa cells. These findings 
imply that SYNPO functions differently from SYNPO2 under the chosen experimental 
conditions. Challenging the cells with increased cellular stress to enhance the induction 
of BAG3 mediated degradation could potentially have a different effect on SYNPO 
turnover. Thus similar functions of SYNPO and SYNPO2 in protein degradation can not 
be excluded. 
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Immunofluorescent staining of SYNPO in HeLa cells reveals a punctate pattern. These 
SYNPO punctae are largely increased in size upon overexpression of the largest of the 
three SYNPO isoforms: SYNPOc. These SYNPOc punctae often show small pointed 
protrusions and sometimes appear as ring like structures. Furthermore, BAG3 is 
recruited to these SYNPOc punctae in immunofluorescence experiments. For elucidation 
of the molecular functions of SYNPO punctae and the role of SYNPO – BAG3 
interaction, immunofluorescent co-staining experiments with several marker proteins for 
e.g. aggresomes, the cytoskeleton, lysosomes or endosomes were conducted. A co-
localization of SYNPOc punctae with the early endosome marker EEA1 (early endosome 
antigen 1) could be observed pointing to a potential involvement of SYNPO in 
endosomal transport or processing. In addition new binding partners of SYNPO could be 
identified via immunoprecipitation followed by mass spectrometry, one of them being the 
actin associated protein Annexin A2 (ANXA2). These findings further underscore a 
potential involvement of SYNPO in endosomal transport, as ANXA2 has been previously 
described to play a role in endosomal trafficking. The exact mechanism of SYNPO 
involvement in endosomal transport, and how BAG3 might contribute to this process, 
remains to be a topic for further investigation. 
Besides confirming SYNPO as a novel binding partner of BAG3, this work provides 
fundamental information on SYNPO behavior in HeLa cells. The nature of BAG3 – 
SYNPO interaction could be further characterized and new interaction partners of 
SYNPO could be identified. In addition, this work provides first experimental data linking 
SYNPO, possibly together with BAG3, to endosomes, shedding light in potential 
molecular functions of SYNPO in HeLa cells. 
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1. Introduction 
 
1.1 Protein homeostasis 
Specificity and accuracy are essential for every cell and the organism it is part of. 
Depending on the context, cells need to grow, divide, migrate, polarize or even die to 
ensure an organism’s viability. To do so, cells are equipped with an intricate network of 
signaling pathways which allow a cell to constantly adapt to its ever changing 
surroundings. In the transduction of such signals, proteins are the key players. The entity 
of all proteins of a cell is called its proteome and comprises a vast amount of different 
proteins each having (a) specific function(s). Proteins can interact with each other, react 
to changes in and outside of the cell, bind to cellular membranes and much more. 
Importantly, all these interactions are either highly specific or tightly controlled and 
depend on the three dimensional structure and charge of the respective proteins. Minor 
defects in protein conformation can already result in a loss of its function or its 
aggregation with other proteins. Here molecular chaperones come into play. They are a 
group of enzymes, with various cofactors, aiding in protein folding, function in protein 
quality control and ultimately can direct proteins to be degraded whenever the correct 
native protein structure cannot be attained. The constant effort of a cell to maintain the 
balance between protein synthesis, function and degradation is called protein 
homeostasis, or proteostasis (figure 1.1). 
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Figure 1.1: Overview proteostasis. Chaperones assist in folding of newly synthesized 
or unfolded proteins. Under pathophysiological conditions unfolded proteins may 
aggregate. To prevent aggregation, irreversibly damaged or unfolded proteins need to be 
degraded. Degrading chaperone-complexes assist in degradation of client proteins by 
either the proteasomal or the lysosomal / autophagy pathway. 
 
Protein misfolding can have many reasons such as mutations in their genetic code or 
cellular stress e.g. nutrient deprivation, oxidative stress or mechanical force. Misfolding 
leads to exposition of hydrophobic residues within the amino acid sequence of the 
protein, which are hidden inside of the protein when folded in its correct tertiary structure. 
Thus it is essential that protein folding is tightly and thoroughly controlled, as an 
accumulation of misfolded proteins may lead to the formation of potentially toxic 
aggregates. Many severe diseases are associated with protein aggregation such as 
Huntington’s disease or Alzheimer’s disease (reviewed by Bates et al. 2015 and Kumar 
et al. 2015). Aggregate formation however is not necessarily irreversible. Usually 
misfolded proteins are detected by chaperones, which help unfolded proteins to fold 
correctly or mark them for degradation through the attachment of one or many ubiquitin 
moieties, eventually leading to their degradation via the ubiquitin-proteasome pathway. 
For the degradation of larger protein compounds including aggregates or even entire 
cellular organelles, like mitochondria, another pathway exists, namely the autophagic-
lysosomal pathway (Glick et al. 2010). The lysosome provides an acidic pH and an array 
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of proteases, which specifically cleave target proteins into small peptides leading to their 
degradation. 
Three types of autophagy have been defined, being macro-autophagy, micro-autophagy 
and chaperone-mediated autophagy. In micro-autophagy the lysosome directly takes up 
cytosolic components for degradation by invagination of its membrane (Li et al. 2012). In 
chaperone-mediated autophagy the client protein is bound by chaperones and their 
respective cofactors for direct deliverance to the lysosome without preceding formation 
of an autophagosome. These chaperone-client complexes are recognized by lysosomal 
surface receptors and translocated across the lysosomal membrane to be degraded 
inside (Cuervo and Wong 2014). The only type of autophagy that involves an 
intermediate step is macro-autophagy. Here cargo is delivered to the lysosome through a 
double-membrane vesicle, called the autophagosome, which ultimately fuses with a 
lysosome (Feng et al. 2014) (figure 1.2). 
 
 
Figure 1.2: Formation of Autophagosomes. Macro-autophagy involves multiple steps 
ultimately resulting in the autolysosome in which intracellular substrates are degraded. 
First a phagophore begins to form at the phagophore assembly site (PAS). The 
phagophore membrane continuously expands and thereby engulfs its substrates leading 
to a mature autophagosome. The autophagosome then fuses with a lysosome which 
provides acidic hydrolases and proteases to generate an autolysosome capable of 
degrading its content (Figure is modified and taken from Behl (2016)).  
 
Recent findings also show an involvement of chaperones and their cofactors in the 
macro-autophagy pathway, where they initiate or facilitate autophagosome formation. 
This supports the hypothesis that autophagy is a highly selective process, rather than a 
random uptake of cytosolic components (Arndt et al. 2010, Crippa et al. 2010, Carra et 
al. 2008).  
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1.2 HSP70 and the BAG family 
A major, and well characterized, family of chaperones is the HSP70 family (heat shock 
protein 70 kDa). It comprises constitutively expressed HSP70, termed HSC70 and 
stress-inducible forms (Murphy 2013). In general, one can regard HSP70 as a small 
machine driven by hydrolysis of ATP. This reaction is possible due to the N-terminally 
located ATPase domain of HSP70 which is coupled to the C-terminal peptide-binding 
domain, consisting of an α-helical lid and a β-sandwich subdomain. Unfolded proteins 
are recognized via their hydrophobic residues by the β-sandwich. Peptides can stably be 
bound by HSP70 through hydrolysis of ATP to ADP, leading to a conformational change 
in the β-sandwich and closure of the α-helical lid (Rüdiger et al. 1997). The hydrolysis of 
ATP and therefore stable substrate binding is supported by HSP40 (heat shock protein 
40 kDa) which accelerates the reaction. HSP40 belongs to a family of co-chaperones 
which, besides enhancing HSP70 function, can also deliver unfolded protein substrates 
to HSP70 (Fan et al. 2003). Substrate release from HSP70 is catalyzed by nucleotide 
exchange factors exchanging ADP for ATP and thereby promote opening of the α-helical 
lid of HSP70 (reviewed by Hartl et al. 2011, Mayer 2010). 
For the selectivity of chaperone function their cofactors or co-chaperones play an 
important role as they facilitate recognition and release of client proteins, recruitment of 
ubiquitin ligases, substrate delivery to the autophagic machinery and many more 
processes (Caplan 2003, Edkins 2015, Arndt et al. 2010). Among the vast variety of thus 
far identified co-chaperones is the Bcl-2 associated athanogene 3 (BAG3). 
BAG3 is one of six proteins, which constitute the human BAG family. BAG1 was the first 
family member to be identified in 1995 as a Bcl-2 (B-Cell lymphoma 2) binding protein. It 
could be shown that BAG1 has an anti-apoptotic effect, especially in combination with 
Bcl-2. This anti-apoptotic function of BAG1 also gave rise to its name as the term 
“athano” is derived from the Greek word “athanos” which means anti-death (Takayama 
et al. 1995). Another four members of the BAG family (BAG 2 – 5) were identified shortly 
afterwards by a yeast two-hybrid screen with the ATPase domain of HSC/HSP70 as bait. 
The conserved binding domain responsible for the interaction of BAG family members 
with the HSC/HSP70 ATPase domain was termed BAG domain and is shared by all 
members of the BAG family (Takayama et al. 1999) (figure 1.3). Only two years later it 
could be shown, that BAG1 promotes release of substrate from HSP70 by binding to the 
ATPase domain via its BAG domain (Sondermann et al. 2001). Therefore BAG family 
members act as nucleotide exchange factors assisting HSC/HSP70 in substrate release, 
making BAG family members co-chaperones. 
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Figure 1.3: The BAG protein family. Schematic representation of the human family of 
BAG proteins. Each member has a C-terminally located BAG domain and differing 
domains and motifs throughout their N-termini and central sequence. UBL – ubiquitin-like 
domain, WW – WW-domain, IPV – IPV (Ile-Pro-Val) motif, PXXP – proline rich region. 
Data shown in this figure was obtained from the UniProt database 
(http://www.uniprot.org). 
 
 
1.3 The co-chaperone BAG3 
In this work, focus was laid on the BAG family member 3 (BAG3). Two isoforms have 
been reported for BAG3, which can be detected by Western Blot at roughly 80 and 40 
kDa (Rosati et al. 2011, Bruno et al. 2008). BAG3 expression could be shown in various 
tissues under cellular stress conditions, whereas BAG3 is constitutively expressed in 
skeletal muscle, the heart and cancer cells (Homma et al. 2006). Interestingly BAG3 
expression is induced under cellular stress such as oxidative stress, HIV-1 infection or 
mechanical stress (Bonelli et al. 2004, Rosati et al. 2007 and 2009, Ulbricht et al. 2015). 
Like all BAG family members also BAG3 can interact with Bcl-2 via its BAG domain and 
acts as an anti-apoptotic protein (Lee et al. 1999). Furthermore BAG3 contains various 
other motifs and domains for protein-protein interactions such as an N-terminally located 
WW-domain, two IPV (Ile-Pro-Val) motifs and a centrally located proline rich (PXXP) 
repeat region, completed by a C-terminal LEAD motif for Caspase 9 cleavage (Merabova 
et al. 2015, Fuchs et al. 2010, Chen et al. 2013, Virador et al. 2009) (figure 1.4). Being 
equipped with these diverse domains and motifs, BAG3 shows high potential to be 
involved in various cellular pathways. This potential has been proven true by linkage of 
BAG3 to biological processes ranging from apoptosis, cytoskeleton arrangement, cell 
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adhesion and migration, to developmental processes, protein folding and autophagy 
(Lee et al. 1999, Iwasaki et al. 2007 and 2010, Shi et al. 2016, Choi et al. 2006, De 
Marco et al. 2011, Behl 2016, Arndt et al. 2010, Gamerdinger et al. 2011).  
 
 
Figure 1.4: The human co-chaperone BAG3. BAG3 comprises various domains and 
motifs for protein-protein interaction being an N-terminal WW-domain with the capability 
of interaction with proteins like SYNPO2 or AMOTL1. Two IPV motifs for interaction with 
the small heat shock protein HSPB8, two RSQS motifs in close proximity for interaction 
with 14-3-3 (here indicated by only one light green line), a proline rich region which 
mediates binding to the motor protein dynein and a C-terminal BAG-domain for 
interaction with HSP70/HSC70 and Bcl-2. Additional protein binding partners of BAG3 
are given below each domain / motif. Data obtained from the UniProt database 
(http://www.uniprot.org). 
 
 
1.4 BAG3 in cancer 
Many studies describe BAG3 to play a role in various types of cancer. In non-small cell 
lung cancer BAG3 is described to promote resistance to apoptosis (Zhang et al. 2012). 
This anti-apoptotic activity of BAG3 in tumors has also been reported for other types of 
tumors like thyroid carcinomas (Chiappetta et al. 2006), neuroblastoma cells (Gentilella 
et al. 2008), colon cancer (Aaron et al. 2009), kidney cancer (Wang et al. 2009) and 
pancreatic cancer (Liao et al. 2001). In hepatocellular carcinomas increased BAG3 levels 
can inhibit cellular proliferation via an interaction with glucose-6-phosphate 
dehydrogenase, a pentose phosphate pathway enzyme (Kong et al. 2016). Through the 
function as a co-chaperone of HSP70, BAG3 is involved in many additional cancer cell 
signaling pathways. For example the transcription factor nuclear factor κB (NF-κB) 
signaling, an essential pathway for cellular survival, or the cell cycle regulator p21 
(Colvin et al. 2014). The many roles of BAG3 in tumor development and progression 
make it a potential target for cancer therapy. A small molecule inhibitor, YM-1, which 
disrupts the HSP70-BAG3 complex has been identified and successfully used in mice to 
Introduction  11 
______________________________________________________________________ 
 
suppress tumor growth (Colvin et al. 2014). Furthermore JG-98, an allosteric inhibitor of 
the HSP70-BAG3 protein interaction, was tested in xenograft models revealing elevated 
p21 levels and limited tumor growth (Li et al. 2015). 
1.5 BAG3 knockout mice and myopathies 
In the model organism Drosophila melanogaster only one BAG family protein is 
expressed called Starvin. Homozygous mutant alleles of Starvin lead to an early death of 
Drosophila larvae during the first larval instar. This is due to their inability to take up food 
resulting in the lack of body size increase and death by starvation (Coulson et al. 2005, 
Arndt et al. 2010). Flies with a heterozygous knockout for Starvin reach adulthood, but 
develop a progressive myopathy (Arndt et al. 2010). This could also be shown in BAG3 
deficient homozygous knockout mice which develop normally, but postnatally develop a 
severe myopathy and die by 4 weeks of age (Homma et al. 2006). Together this 
indicates that BAG3 / Starvin is not essential for muscle development during 
embryogenesis but crucial for postnatal skeletal muscle homeostasis (Coulson et al. 
2005, Arndt et al. 2010). BAG3 knockout mice generated with the cre-LoxP system by 
Youn et al. (2008) also showed growth retardation and death by three weeks of age. 
Furthermore, it was shown that the mice showed hypoglycemia, a reduction of white 
blood cells, splenocytes and thymocytes and a reduction of weight of the thymus and 
spleen (Youn et al. 2008).  
In humans several mutations of the BAG3 gene are described in myopathies 
predominantly affecting the heart (dilated cardiomyopathy) eventually resulting in heart 
failure (Norton et al. 2011, Villard et al. 2011, Franaszczyk et al. 2014). Patients with a 
point mutation in the BAG3 gene which leads to an amino acid substitution of proline 209 
to leucine (BAGP209L) show a combination of cardiomyopathy and myofibrillar myopathy 
with very early onset in childhood. On cellular level BAGP209L patients show disintegration 
of Z-discs and myofibrils with additional aggregation of BAG3 and other Z-disc proteins 
like desmin or filamin (Kostera-Pruszczyk et al. 2015, Selcen et al. 2009). 
Together this leads to the conclusion that BAG3 is important for postnatal growth and 
survival, with a considerable effect on food uptake and muscle function. 
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1.6 BAG3 in protein homeostasis 
Through its interaction with HSP70, BAG3 is directly involved in protein homeostasis. 
Like all BAG family members it acts as a nucleotide exchange factor aiding in substrate 
release from HSP70 (Sondermann et al. 2001, Arndt et al. 2010). In addition to this, 
several studies show an involvement of BAG3 in selective macro-autophagy pathways, 
where it assists substrate selection. BAG3 directly links HSP70 to these selective macro-
autophagy pathways and has also been shown to be able to recruit autophagic adaptor 
proteins to sites of phagophore assembly (Ulbricht et al. 2013, Kathage et al. 2017) A 
peptide screen for BAG3 interaction partners which specifically bind to its WW-domain 
resulted in the identification of Synaptopodin 2 (SYNPO2) (PhD thesis Ulbricht 2013). It 
could be shown, that interaction of BAG3 with SYNPO2 is important for autophagosome 
formation during tension-induced chaperone assisted selective autophagy (CASA) in 
muscle cells (Arndt et al. 2010, Ulbricht et al. 2013 and 2015). Here, unfolded / damaged 
filamin, a cytoskeletal protein responsible for cross-linking of actin filaments in the 
cytoskeleton and at the Z-disk of striated muscle, is specifically recognized by a complex 
consisting of HSP70, HSPB8 and BAG3 (Nakamura et al. 2011, Ulbricht et al. 2013). 
HSP70 recruits the ubiquitin ligase CHIP which, together with the ubiquitin conjugating 
enzyme 4/5, mediates poly-ubiquitination of filamin and thereby labels it for degradation 
via the autophagic pathway (Arndt et al. 2010, Murata et al. 2001). With the help of its N-
terminal PDZ-domain, SYNPO2 is able to interact with the membrane tethering proteins 
VPS18 and VPS16 (Vacuole Protein Sorting 18 and 16), key components of membrane 
tethering complexes responsible for recognition and interaction of two independent 
membranes (Chia and Gleeson, 2014). Furthermore the SNARE-protein (soluble NSF 
attachment receptors) Syntaxin 7, a catalysator of membrane fusion (Mullock et al. 2000) 
was identified to be in a complex with SYNPO2. Interaction of BAG3 with SYNPO2 
therefore enables recruitment of a complex mediating the formation of autophagosomes 
to the CASA machinery (Ulbricht et al. 2013).  
The specific recognition and degradation of filamin is important since filamin functions as 
a cross-linking agent of actin and is under extra- and intracellular strain. This strain 
causes a partial, reversible unfolding of filamin. However, unfolded filamin is prone to 
aggregation which leads to loss of its ability to refold to its native conformation. 
Cytoskeletal maintenance therefore requires a constant degradation and replacement of 
irreversibly unfolded filamin which involves BAG3 as described above. Intriguingly, BAG3 
does not only mediate the specific disposal of damaged filamin, but also is involved in 
stimulating filamin transcription. Via its WW-domain BAG3 can interact with LATS1 
(Large Tumor Suppressor Kinase 1) and AMOTL1 (Angiomotin Like 1) (Ulbricht et al. 
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2013), which are inhibitors of the transcription factors YAP (Yes Associated Protein 1) 
and TAZ (WW Domain Containing Transcription Regulator 1 (WWTR1)) of the Hippo 
signaling pathway (reviewed by Salah and Aqeilan, 2011 and Wang et al. 2017). By 
BAG3 binding to LATS1 and AMOTL1 respectively, YAP and TAZ are released and can 
translocate into the nucleus to initiate, next to many other target genes, filamin 
transcription (Dupont et al. 2011, Ulbricht et al. 2013) (figure 1.5). 
 
Figure1.5: BAG3 in chaperone assisted selective autophagy (CASA) and filamin 
transcription. Overview of specific filamin degradation in muscle cells mediated by 
BAG3 in complex with HSC70, HSPB8, CHIP and SYNPO2. Unfolded filamin is 
recognized by the CASA machinery and delivered to the autophagosome via BAG3 – 
SYNPO2 and ubiquitin – p62 interaction. On the left side involvement of BAG3 in 
YAP/TAZ activation is depicted. BAG3 binds to the YAP/TAZ inhibitors LATS1/2 and 
AMOTL1/2 via its WW-domain and thereby releases YAP/TAZ for translocation to the 
nucleus where they act as transcription factors for filamin and other proteins. Figure was 
modified and taken from Ulbricht et al. 2013. 
 
It has been long known that under cellular stress, like nutrient deprivation, mechanical 
strain or oxidative stress, autophagy is employed for recycling of nutrients and other 
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cellular components to ensure survival (reviewed by Bento et al. 2016, Navarro-Yepes et 
al. 2014, Ulbricht et al. 2013). Interestingly, BAG3 expression is up-regulated under 
acute cellular stress, in aged cells or by the inhibition of the proteasome (Gamerdinger et 
al. 2009). Under physiological conditions BAG-family member dependent degradation of 
proteins is mediated by BAG1 and HSP70 which guide client proteins to the ubiquitin-
proteasomal-pathway (Lüders et al. 2000). Pathophysiological conditions however give 
rise to an increased cellular level of BAG3 protein, thereby turning on BAG3-mediated 
selective autophagy. This mechanism also referred to as the “BAG1 – BAG3 Switch” 
allows a cell to adapt to and react to cellular stress (Gamerdinger et al. 2009). BAG3 has 
been reported to sequester ubiquitinated proteasomal clients to cytoplasmic punctae 
upon proteasome inhibition. These punctae can be co-labeled for LC3, a marker for 
autophagosomes (Minoia et al. 2014). Furthermore BAG3 is actively involved in the 
formation of perinuclear compartments called aggresomes (Gamerdinger et al. 2011). 
Aggresomes can be referred to as a kind of collecting point for proteins marked for 
degradation by autophagy (reviewed by Kopito, 2000). Aggresome targeting of client 
proteins is achieved by an interaction of BAG3 with the microtubule-motor protein 
dynein, thereby selectively directing HSP70 bound substrates to the motor and 
subsequently to the aggresome (Gamerdinger et al. 2011). An example for this BAG3 
mediated transport is mutated SOD1 (Superoxide Dismutase 1), a protein linked to 
amyotrophic-lateral-sklerosis (ALS) and an established HSP70 substrate (Wang et al 
2009). SOD1 is specifically directed to aggresomes through BAG3 mediated coupling of 
SOD1 to the dynein motor (Gamerdinger et al. 2011). In support of these findings 
isoforms of 14-3-3 protein, which have been previously described to play a role in 
aggresome formation (Waelter et al. 2001, Omi et al. 2008, Wang et al. 2009), were 
shown to act as adaptor for dynein – BAG3 interaction and to recruit motor cargo for 
transport to the aggresome (Xu et al. 2013). 
 
 
1.7 The actin cytoskeleton 
Also important for cellular integrity is the cytoskeleton. It generally consists of three main 
components which are actin-filaments, microtubules and intermediate filaments. 
Together they are responsible for many essential functions of the cell such as spatial 
organization of cellular content, connecting the cell to the extracellular matrix and 
generation of force to enable cellular movement and changes of shape (reviewed by 
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Fletcher and Mullis, 2010). Next to these fundamental processes, the actin cytoskeleton 
has been described in many important cellular functions such as endocytosis (Morel et 
al. 2009), autophagy (Mi et al. 2015, reviewed by Coutts and La Thangue, 2016) and 
intracellular transport (reviewed by Khaitlina, 2014). Therefore, it is not surprising that 
actin is a highly conserved protein and one of the most abundantly expressed proteins in 
eukaryotic cells (reviewed by Dominguez and Holmes, 2011). Via dynamic remodeling 
and the interplay of the actin cytoskeleton with an ever growing number of actin-binding 
proteins (ABPs) the diverse and highly complex cellular activities mentioned above can 
be accomplished. Actin exists in two forms namely the monomeric / globular G-actin and 
the filamentous F-actin. Being an ATPase, actin can switch between its two forms in an 
ATP dependent manner, tightly regulated by ABPs. As indicated by their respective 
names, G-actin is monomeric and not incorporated into actin filaments, whereas F-actin 
is the major component of actin filaments. Generally actin filaments are asymmetric with 
a barbed end (or + end), which is the growing site of an actin filament and the pointed 
end (or – end) of the filament at which de-polymerization occurs. Continuous 
polymerization and de-polymerization is referred to as actin treadmiling (reviewed by 
Carlier and Shekhar, 2017). In addition to treadmilling, generation and maintenance of 
an intact and dynamic actin cytoskeleton requires constant nucleation of new filaments, 
branching, crosslinking, severing and capping, mediated with the help of ABPs. Some of 
the most important actin regulating ABPs are the Rho family GTPases Rho, Rac and 
Cdc42. They control the assembly of stress fibers (Rho), lamellipodia (Rac) and filopodia 
(Cdc42), in response to extra – and intracellular signals (Asanuma et al. 2006, Krugman 
et al. 2001, reviewed by Raftopoulou and Hall, 2004). Lamellipodia consist of highly 
branched actin filaments at the leading edge of a migrating cell. Via actin treadmilling, 
force is generated to move the cell forward. Filopodia are cellular protrusions reaching 
beyond the leading edge, sensing the environment whereas stress fibers span the cell 
and link it to the extracellular matrix via focal adhesions and adherens junctions 
(reviewed by Le Clainche and Carlier, 2008). It becomes apparent, that dynamic actin 
cytoskeleton rearrangement is essential for cellular function. But how is actin 
polymerization initiated? Actin filament polymerization occurs in three phases: 
nucleation, elongation and steady state. Formins mediate de novo nucleation of 
unbranched actin filaments such as stress fibers and filopodia by promoting the 
interaction between two actin monomers (reviewed by Lee and Dominguez, 2010). For 
nucleation of actin monomers from existing filaments the Arp2/3 (actin related proteins 
2/3) complex comes into play as an inductor of branched actin filaments like lamellipodia 
(Wu et al. 2012, Rogers et al. 2003, Mejillano et al. 2004). Nucleation is followed by 
elongation of the actin filament by incorporation of G-actin into the filament via ATP 
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hydrolysis. This is facilitated by ABPs such as profilin which can bind directly to the FH1 
domain of formins (Romero et al. 2004). The steady state of actin filament polymerization 
describes the state of actin treadmilling described above in which new G-actin is 
integrated at the barbed end and F-actin dissociates from the pointed end of the actin 
filament. In their review, Fletcher and Mullins (2010) nicely compare cytoskeletal building 
blocks to the popular toy LEGO, as both consist of multiple copies of key pieces which 
can be put together to form larger structures which can be disassembled and 
reassembled for specific function according to cellular needs. 
A role of BAG3 in cellular migration and adhesion could be established as homozygous 
BAG3 deficient mouse embryonic fibroblasts show delayed filopodia and focal adhesion 
formation and reduced motility (Iwasaki et al. 2007). In muscle cells BAG3 has been 
shown to interact with and stabilize the actin capping protein CapZ in order to maintain 
myofibrillar integrity (Hishiya et al. 2010). In striated muscles the BAG3 interacting 
protein SYNPO2 localizes together with BAG3 at Z-disks which are actin anchoring 
structures. Through CASA, BAG3 and SYNPO2 are involved in Z-disk maintenance via 
filamin degradation (as described above) (Ulbricht et al. 2013). A common feature of the 
SYNPO family proteins is their ability to bind to actin, this includes the family member 
and novel BAG3 interactor Synaptopodin (SYNPO), which will be discussed in the 
following chapter. 
 
 
1.8 The actin-binding protein Synaptopodin (SYNPO) 
SYNPO2 which was, as mentioned above, identified to bind to BAG3 in CASA, belongs 
to the SYNPO family of proteins defined by sequence homology and their ability to bind 
to actin (Chalovich abd Schroeter 2010). The peptide screen for interaction partners of 
the BAG3 WW-domain which lead to the identification of SYNPO2 as binding partner of 
BAG3 also detected SYNPO as a possible BAG3 WW-domain interactor (PhD thesis 
Ulbricht 2013, unpublished data). The SYNPO family comprises at least four members 
being Synaptopodin (SYNPO), SYNPO2 (also termed Myopodin), SYNPO2-like protein 
and Fesselin (Weins et al. 2001, Schroeter et al. 2008). SYNPO, the founding member 
and eponym of the SYNPO family, was first identified in 1991 as a protein of 44 kDa in 
size, which is expressed in podocytes of rat kidney glomeruli (Mundel et al. 1991). Later 
on it was shown that the originally identified 44 kDa SYNPO is a proteolytic fragment of 
full length SYNPO, which can be detected in Western Blot experiments at 100 kDa (rat 
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forebrain) or 110 kDa (rat kidney) (Mundel et al. 1997). Furthermore SYNPO was shown 
to localize in punctae, which co-localize with the actin cytoskeleton in 
immunofluorescence experiments, and was also detected in focal contacts (Mundel et al. 
1997). SYNPO is involved in the bundling and elongation of actin filaments by interaction 
with the actin crosslinker α-actinin and is therefore a dual actin / α-actinin binding protein 
(Kremerskothen et al. 2005). Knockout of SYNPO in murine podocytes results in a 
significant delay in reformation of actin stress fibers after treatment with the actin 
depolymerizing agent cytochalasin D (Asanuma et al. 2005). Actin stress fibers are 
specific for non-muscle cells and are composed of actin and non-muscle myosin II. In 
addition they interact with various crosslinkers such as α-actinin-4. They are important 
for cell adhesion, morphogenesis, migration and mechanotransduction as they can 
produce force by movement of myosin II motor domains along the actin filaments (figure 
1.6) (reviewed by Tojkander et al. 2012). 
 
Figure 1.6: Schematic representation of stress fibers and their orientation and 
components. Four types of stress fibers are distinguished from each other by their 
cellular localization, orientation, composition and association with focal adhesions. The 
most important components of actin stress fibers are α-actinin and non-muscle myosin II 
as indicated in red and blue. Figure is taken from Tojkander et al. (2012). 
 
Besides other functions mentioned above, stress fibers are associated with wound 
healing. It could be shown that SYNPO expression is up-regulated under laminar shear 
stress in endothelial cells and that SYNPO plays a role in endothelial wound healing. It is 
hypothesized that SYNPO participates in wound healing because of its ability to remodel 
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the actin cytoskeleton, which promotes cellular migration and wound closure (Mun et al. 
2014). The effect of SYNPO on cellular migration has also been described by Asanuma 
et al. (2006), who could show that podocyte migration is impaired upon gene disruption 
of SYNPO. Furthermore, they were able to link SYNPO to RhoA in stress fiber formation. 
RhoA belongs to the Rho family of small GTPases and promotes stress fiber formation in 
vivo (reviewed by Ridley, 1997). The role of SYNPO in stress fiber formation is to block 
(by competitive binding) Smurf-1-mediated ubiquitylation of RhoA and thereby preventing 
its degradation via the proteasome (Asanuma et al. 2006). This shows that SYNPO is 
not only a component of stress fibers but also a modulator of their formation. In 
podocytes, SYNPO has been shown to interact with 14-3-3β and 14-3-3η, chaperone-
like phospho-serine / thereonine-binding proteins, in a phosphorylation dependent 
manner. 14-3-3β interaction protects SYNPO from Cathepsin-L mediated cleavage and 
thereby preserves SYNPO induced stress fiber formation (Faul et al. 2008). 
Homozygous knockout mice for SYNPO have been reported to lack spine apparatuses in 
excitatory neurons and show deficits in spatial learning (Deller et al. 2003). Together 
these data indicate various roles of SYNPO in cytoskeletal integrity and neuronal 
function and give first hints on an involvement of SYNPO in mechanotransduction. 
 
 
1.9 Aim of the work 
The precise regulation of chaperone assisted selective autophagy is crucial for protein 
homeostasis and muscular maintenance. Together with SYNPO2, the co-chaperone 
BAG3 is indispensable for the degradation and synthesis of filamin under mechanical 
strain (Ulbricht et al. 2013).  
This work was conducted in order to identify and characterize further components 
interacting with BAG3 and their potential involvement in CASA. Here the actin binding 
protein SYNPO, identified in the same peptide screen which originally identified SYNPO2 
as BAG3 binding partner, was chosen as a prominent candidate protein for BAG3 
interaction and CASA function. With its bundling and elongation activity of actin 
filaments, its ability to bind to α-actinin, the PDZ-domain containing protein MAGI-1 and 
its association with actin stress fiber formation (Kreemerskothen et al. 2005, Yanagida-
Asanuma et al. 2007, Faul et al. 2008), SYNPO displays characteristics similar to those 
described for SYNPO2 in muscle cells (Linnemann et al. 2010, Ulbricht et al. 2013). It 
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was of interest whether SYNPO carries out similar functions as SYNPO2 in cells which 
do not express SYNPO2. 
In addition, SYNPO in general was subject for further molecular characterization, as 
there is not much known about SYNPO beyond its roles in podocytes and in neuronal 
context. 
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2. Materials and Methods 
 
2.1 Material 
 
2.1.1 Appliances 
Appliance      Supplier 
Autoclave      Tuttnauer Systec 
Biofuge fresco     Heraeus 
Biofuge pico      Heraeus 
Blot-system (mighty small transfer)   Amersham 
Cooling centrifuge 5415R    Eppendorf 
Cooling centrifuge 5810R    Eppendorf 
Developing machine CURIX 60   AGFA 
Electrophoresis Power supply   Amersham 
Electrophoresis-system HE33   Hoefer 
Extraction system     HLC Biotech 
Freezer (-80°C)     Forma Scientific 
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Freezer (-20°C)     Liebherr / Siemens 
Fridge       Siemens 
Gel-documentation-system Gel Doc   Biorad 
Heating block      Eppendorf 
Ice machine MF22     Scotsman 
Incubator      Heraeus / Binder 
Laminar flow hood     Nalge Nunc Industries 
Light microscope ID03    Zeiss 
LSM Axiovert 100M     Zeiss 
Magnetic stirrer MR2002    Heildolph 
Mastercycler      Eppendorf 
Mastercycler epgradient S    Eppendorf 
Microwave      Bosch 
Milli-Q-Plus Water purifier    Millipore 
pH-meter      Mettler Toledo 
Photometer      Eppendorf 
Pipettes      Eppendorf 
qPCR-Cycler CFX96 Touch    Biorad 
Rotating wheel     Renner 
SDS-Page-system (mighty small II)   Amersham 
Rocking platform     Stuart 
Scale       KernKB 
Special accuracy scale SI-234   Denver Instruments 
Tabletop centrifuge 400R    Heraeus 
Thermo-block      HLC Biotech QBT 
Thermocycler T3000     Biometra 
Thermo-shaker     Medline Scientific 
Ultrasonicator UP100H    Hielscher Ultrasound Technology 
Vortex-Genie 2     Scientific Industries 
Waterbath A100     Lauda 
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2.1.2 Consumables 
Material      Supplier 
Cell culture dishes     Sarstedt 
Common laboratory demand    Faust, Meckenheim 
Fuji X-Ray Film Super RX    Fuji 
Reaction tubes     Eppendorf 
Plasticware      Roth 
 
2.1.3 Kits, enzymes and standards 
Kit       Supplier 
CalPhos-Transfection Kit    Clonetech 
ECL Blot detection      Thermo Fisher Scientific 
iScript cDNA Synthesis Kit    Biorad 
JetPRIME Transfection Kit    Peqlab 
NucleoBond® Xtra Maxi    Macherey-Nagel 
NucleoSpin® Gel and PCR Clean-up  Macherey-Nagel 
NucleoSpin® Plasmid    Macherey-Nagel 
SsoFastTM EvaGreen® Supermix   Biorad 
 
Standard      Supplier 
Gene Ruler DNA Ladder Mix 1 kb   Fermentas 
Prestained Protein Standard Plus   Biorad 
 
Enzyme      Supplier 
Alkaline Phosphatase    Thermo Scientific 
Complete Protease-Inhibitor Cocktail  Roche 
KOD-Polymerase      Millipore 
Lambda Protein Phosphatase   New England Biolabs 
PCR nucleotide mix     Roche 
Restrictionendonucleases    Fermentas 
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RNase A      Segentic 
T4-DNA-Ligase     Thermo Scientific 
 
2.1.4 Chemicals 
Chemical      Supplier 
2-Propanol (Isopropanol)    Roth 
Acetic acid      Roth 
Acrylamide (30%)/bis-Acrylamide   Roth 
Agar       Roth 
Agarose      Roth 
Ampicillin      Roth 
ATP (adenosine triphosphate)   Sigma Aldrich 
Bacto-Yeast extract     Roth 
Bacto-Trypton      Roth 
Bafilomycin A1     LC Labs 
CaCl2 (Calciumchloride)    Roth 
Coomassie Brilliant Blue R250   Sigma Aldrich 
DMSO (Dimethylsulfoxide)    Roth 
DTT (Dithiothreitol)     Sigma Aldrich 
EDTA (Ethylenediaminetetraacetate)  Roth 
Ethanol (absolute)     Roth 
Glucose      Roth 
Glutamine      Life Technology 
Glycerine      Roth 
Glycine      Roth 
HCl        Roth 
HEPES      Roth 
Imidazole      Roth 
K2HPO4      Roth 
Kanamycine      Roth 
KCl       Roth 
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KH2PO4      Roth 
KOH       Roth 
Mercaptoethanole     Roth 
Methanol      Roth 
MG132      Peptanova 
MgCl2       Roth 
MgSO4      Roth 
MOPS       Roth 
MOWIOL®      Calbiochem 
Na2HPO4      Roth 
NaCl       Roth 
NaOH       Roth 
Nonidet p-40      Sigma Aldrich 
Penicillin      Life Technology 
Ponceau S      Roth 
Protein-G sepharose     GE Healthcare 
Puromycine      Calbiochem 
SDS       Roth 
Streptomycin      Life Technology 
TCA       Roth 
TEMED      Roth 
Tris       Roth 
Triton X100      Roth 
Tween-20      Sigma Aldrich 
 
2.1.5 Antibodies 
2.1.5.1 Primary Antibodies 
Antigen    Species   Supplier 
β-actin     mouse    Abcam 
BAG3     rabbit    Proteintech 
EEA1     goat    Santa Cruz 
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FLAG (M2)    mouse    Sigma Aldrich 
γ-Tubulin    goat    Santa Cruz 
LAMP1    mouse    Abcam 
S6-P     rabbit    New England Biolabs 
SYNPO    rabbit    Synaptic Systems 
SYNPO2    rabbit    Prof. Fürst / Uni Bonn 
Ubiquitin (FK2)   mouse    Biomol 
 
2.1.5.2 Secondary Antibodies 
Antigen    Species   Supplier 
Clean Blot    diverse   Thermo Scientific 
Goat IgG + PO   rabbit    Sigma Aldrich 
Goat IgG Alexa Fluor 488  donkey   Abcam 
Mouse IgG    /    Santa Cruz 
Mouse IgG Alexa Fluor 488 nm goat    Invitrogen 
Mouse IgG + PO   goat    Sigma Aldrich 
Rabbit IgG    /    Santa Cruz 
Rabbit IgG Alexa Fluor 488 nm goat    Invitrogen 
Rabbit IgG Alexa Fluor 546 nm goat    Invitrogen 
Rabbit IgG Alexa Fluor 633 nm goat    Invitrogen 
Rabbit IgG + PO   goat    Sigma Aldrich 
True Blot    rat    Rockland 
 
2.1.6 Plasmids 
Plasmid     Comment 
pcDNA 3.1(+)     Expression of proteins in mammalian cells 
w/o t      tag. Under control of a viral promoter. 
pcDNA-BAG3     AG Höhfeld 
pCMV-Tag2B-empty Expression of proteins in mammalian cells 
with N-terminal FLAG-tag. Under control of a 
CMV-promoter (Invitrogen). 
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pCMV-Tag2b-ANXA2    Cloned from human cDNA transcript 
pCMV-Tag2B-BAG3    AG Höhfeld 
pCMV-Tag2B-BAG3-WAWA   AG Höhfeld 
pCMV-Tag2b-SYNPOc   Cloned from human cDNA transcript 
pCMV-Tag2b-SYNPOb   Cloned from human cDNA transcript 
pCMV-Tag2b-SYNPOc-PAAY1st Cloned from pCMV-Tag2b-SYNPOc with 
specific primers containing the desired 
mutations. 
pCMV-Tag2b-SYNPOc-PAAY2nd Cloned from pCMV-Tag2b-SYNPOc with 
specific primers containing the desired 
mutations. 
pCMV-Tag2b-SYNPOc-PPXYdouble Cloned from pCMV-Tag2b-SYNPOc with 
specific primers containing the desired 
mutations. 
pCMV-Tag2b-Vim    Cloned from human cDNA transcript 
pTraffic-LC3      AG Höhfeld 
pTraffic-p62     AG Höhfeld 
pEGFP-BAG3     AG Höhfeld 
pEYFP-Vim     AG Höhfeld 
2.1.7 Oligonucleotides 
Oligonucleotide Sequence (5’à3’) 
Annexin-FW-BamHI  CGCTTTGGATCCATGTCTACTGTTCACGAAATCC 
Annexin2-Rev-XhoI  CGCTTTCTCGAGTCAGTCATCTCCACCACACAG 
qPCR B2M FW  GTGATCTTTCTGGTGCTTGTC 
qPCR B2M RV  AAGTTGGGCTTCCCATTCTC 
qPCR GAPDH FW  GAGAAACCTGCCAAGTATGATGAC 
qPCR GAPDH RV  ATCGAAGGTGGAAGAGTGGG 
SY-Long-FW-HindIII  GCGTTTAAGCTTATGCTGGGTCCTCACCTCCCAC 
SY-Long-Rev-XhoI  GCAAGCCTCGAGTTACTTGAAGCAGAAGGAAGGCTTC 
SY-Long-qPCR-Hu-FW ACACCGCAGCTGCCCAAAGC 
SY-Long-qPCR-Hu-RV TGAAGAGCTGGACGCCACGG 
SYNPO-qPCR-Hu-FW CGTGGAGAAGCCCAAGGTGACC 
SYNPO-qPCR-Hu-RV GCTCCCTTCCCAGAGGCCTC 
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SYNPO-PT610AA-FW ACTTCACTGCACCCGCCGCCTACACTGAGACC 
SYNPO-PT610AA-RV GGTCTCAGTGTAGGCGGCGGGTGCAGTGAAGT 
SYNPO-PS629AA-FW CTGGGTGAGGTCTCCTGCCGCATATTCTGTCCTGTA 
SYNPO-PS629AA-RV TACAGGACAGAATATGCGGCAGGAGACCTCACCCAG 
Vimentin-FW-BamHI  GCGTTTGGATCCATGTCCACCAGGTCCGTGTC 
Vimentin-Rev-HindIII  GCAAGCAAGCTTTTATTCAAGGTCATCGTGATGC 
 
2.1.8 siRNA 
Gene  siRNA   Species  Supplier 
BAG3   Hs_BAG3_5   human   Qiagen 
BAG3   Hs_BAG3_6   human   Qiagen 
SYNPO  GS11346 for SYNPO  human   Qiagen 
 
2.1.9 Bacterial strains, mammalian cell lines 
Strain / Cell line Comment 
E. Coli TG1   Stratagene 
A7r5    embryonal smooth muscle cells from aorta (rattus 
norvegicus) 
Hek-293   embryonic kidney cells (homo sapiens) 
HeLa    Cervical cancer cells (homo sapiens) 
MEF    Embryonic fibroblasts (mus musculus) 
SH-SY5Y   Neuroblasts from neural tissue (homo sapiens) 
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2.2 Methods 
 
2.2.1 Handling of the prokaryote E. Coli 
 
2.2.1.1 Cultivation 
LB.Medium (with Amp/Kan):  1 % Bacto-Trypton 
      0,5 Bacto-Yeast extract 
      0,5 % Nacl 
      pH7,5  à autoclave 
(1:10000 Amp [200 mg/ml] / Kan [50 mg/ml]) 
LB-Agar (mit Amp/Kan):  1 % Bacto-Trypton 
      0,5 Bacto-Yeast extract 
      0,5 % NaCl 
      1,5 % Bacro-Agar 
      pH7,5  à autoclave 
(1:10000 Amp [200 mg/ml] / Kan [50 mg/ml]) 
 
In this work Escherichia Coli (E. coli) was used as an amplification system for cloned 
plasmids. For this purpose E. coli were transformed by heat shock and incubated 
overnight on LB-agar plates containing either ampicillin or kanamycin for positive 
selection of bacteria carrying the desired plasmid. This was followed by overnight 
incubation at 37°C of a positively transformed single E. coli colony in 3 to 5 mL of 
antibiotic containing LB medium at 200 rpm. The obtained cells were centrifuged and 
further processed in plasmid isolation. 
 
2.2.1.2 Competent cells 
For successful transformation of bacteria via heat shock they need to be “made 
competent” for receiving DNA. This was done by inoculating LB-medium with the E. coli 
strain TG1 and over night incubation at 37°C and 130 rpm. 1 mL of the overnight culture 
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was used for inoculation of 100 mL LB-medium containing ampicillin. This was incubated 
at 37°C and 130 rpm until an optical denisity of 0.5 (measured at 600 nm (OD600)) was 
reached. The bacteria were then centrifuged for 10 min at 4000 rpm and 4°C after which 
the supernatant was discarded. The remaining pellet was re-suspended in ice cold 80 
mM CaCl2-solution which induces the chemical competence. After that the bacteria were 
incubated for 30 min on ice, followed by centrifugation for 10 min at 4°C and 4000 rpm. 
The supernatant was discarded again and the pellet re-suspended in 100 mM CaCl2-
solution containing 20% glycerin. For storage aliquots of 100 µL were frozen at -80°C. 
 
2.2.1.3 Transformation of E. coli via heat shock 
Competent bacteria (see above) are capable of taking up plasmids from their 
environment. For this 12 µL of a ligation or 0.5 µg purified plasmid is pipetted on 100 µL 
competent TG1 cells and incubated for 30 min on ice. This was followed by a 50 sec 
heat shock at 42°C with subsequent addition of 1 mL LB-medium. The transformed 
bacteria were incubated for 1 h at 37°C and roughly 350 rpm. For positive selection the 
bacterial suspension was plated on LB-agar plates containing either ampicillin or 
kanamycin and incubated over night at 37°C. Successfully transformed cells were now 
able to create colonies by cell division. These plasmid containing colonies were then 
further amplified with subsequent purification of the plasmid DNA. 
 
2.2.2 Handling of eukaryotic cell lines 
 
2.2.2.1 Cultivation 
 Cell Culture Medium A7r5:  Dulbecco’s Modified Eagle Medium 
 10 % FCS 
100 IU/mL Penicillin 
100 IU/mL Streptomycin 
4 mM L-Glutamine 
 
 Cell Culture Medium Hek-293: Dulbecco’s Modified Eagle Medium 
10 % FCS 
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100 IU/mL Penicillin 
100 IU/mL Streptomycin 
2 mM L-Glutamine 
Pyruvate 
Non-essential amino acids 
 
 Cell Culture Medium HeLa:  Dulbecco’s Modified Eagle Medium 
10 % FCS 
100 IU/mL Penicillin 
100 IU/mL Streptomycin 
 
 Cell Culture Medium MEF:  Dulbecco’s Modified Eagle Medium 
10 % FCS 
100 IU/mL Penicillin 
100 IU/mL Streptomycin 
 
 Cell Culture Medium SH-SY5Y: Dulbecco’s Modified Eagle Medium 
15 % FCS 
100 IU/mL Penicillin 
100 IU/mL Streptomycin 
2 mM L-Glutamine  
Pyruvate 
Non-essential amino acids 
 
PBS:     
137 mM NaCl 
2.7 mM KCl 
8 mM Na2HPO4 
1.4 mM KH2PO4 
pH 7.4   à autoclave 
 
Trypsin-Solution:   0.05 % Trypsin / EDTA 
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All cell lines were cultivated at 37°C, 5% CO2 content and 95 % humidity. Before 
reaching confluence, cells were split into new cell culture dishes. Here culturing medium 
was discarded and cells were washed with PBS once, followed by the addition of 1 mL 
Trypsin-Solution. The following incubation times at 37°C were applied until cells were 
successfully detached from the surface of the cell culture plate: A7r5 – 5-10 min; Hek-
293 – 5 min; HeLa – 3 min; MEF – 3 min and SH-SY5Y – 10 min. The detached cell 
suspension was resuspended in the respective pre-warmed medium and split in the 
following ratios: A7r5 – 1:3; Hek-293 – 1:6; HeLa – 1:10; MEF – 1:10 and SY5Y – 1:5. 
 
2.2.2.2 Transfection of HeLa cells with Calcium Phosphate 
 2x HBS:   1.6 g NaCl 
     0.74 g KCl 
     0.0027 g Na2HPO4 
     0.2 g Glucose 
     1.19 g HEPES 
     pH 7.05 
     ad 100 mL with aqua bidest. à sterile filtration 
 CaCl2-Solution:  2.5 M CaCl2   à sterile filtration 
 
The cells were split one day before transfection so that a ~ 40 – 60 % confluence was 
reached. Cell culture medium was exchanged with fresh medium prior to transfection. 
For transfection of cells grown in 10 cm cell culture dishes the following transfection 
reaction was prepared: 
     20 µg Plasmid-DNA 
     86.8 µL CaCl2-Solution 
     ad. 700 µL H2O 
 
Plasmid-DNA was first diluted in the respective volume of sterile H2O and shortly 
vortexed after the addition of the CaCl2-solution. Whilst slightly vortexing the same 
volume (700 µL for 10 cm dishes) 2x HBS was added drop by drop to the prepared 
Plasmid-DNA containing solution. This was followed by a 5 min incubation at RT for the 
development of calcium phosphate precipitates. The reaction mix was then pipetted drop 
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by drop onto the prepared cells. After incubation of the transfected cells for 8 h, cell 
culture medium containing the transfection reaction mix was discarded, cells were 
washed once with PBS and fresh, pre-warmed culturing medium was given onto the 
cells. After 48 h incubation cells were harvested for following experiments. For the 
transfection of cells cultured in cell culture dishes of differing volumes, the transfection 
reaction mix is adjusted to the growth area of the respective dish. 
2.2.2.3 Liposome mediated transfection of HeLa cells 
For transfection of HeLa cells with siRNA or Plasmid-DNA the JetPrime-Kit from Peqlab 
was used. Here cells were split the day before transfection to grow to a confluence of 
about 25 – 40 %. Cells were transfected according to the manufacturers’ protocol with 4 
µg DNA (10 cm dishes) or 100 – 200 pmol siRNA (6 cm dishes). Medium was replaced 
by fresh, pre-warmed cell culture medium after 8 h. After 48 h incubation time cells were 
either re-transfected with siRNA or harvested for further use. 
 
2.2.2.4 Treatment of HeLa cells with inhibitors 
For the inhibition of the proteasome or autophagy, HeLa cells were treated with the 
following inhibitors at a confluence of 80 % for 16 h overnight, followed by harvest of the 
cells for experimental use. 
   MG132:  final concentration: 10 µM 
   Bafilomycin A1: final concentration: 200 nM 
   E64d:   final concentration: 20 µM 
 
 
 
2.2.3 Methods in molecular biology 
 
2.2.3.1 Plasmid preparation (MAXI/Mini) 
For purifying plasmid-DNA from E. coli, the NucleoSpin® Plasmid Kit from Macherey-
Nagel (bacterial culture volume of 3 – 4 mL) or the NucleoBond® Xtra Maxi Kit also from 
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Macherey-Nagel (bacterial culture volume of 300 mL) were used. Plasmid preparation 
was performed according to the instructions given by the manufacturers. 
 
2.2.3.2 Polymerase Chain Reaction (PCR) 
Polymerase Chain Reaction (PCR) is used to specifically amplify nucleotide sequences. 
A PCR generally consist of three phases which are repeated for about 30 times to 
exponentially amplify the desired genetic sequence. The four phases of a PCR are the 
following: DNA denaturation at 95°C, annealing of oligonucleotide primers to the 
template sequence (temperature is dependent on the primer pair used) and elongation of 
the aligned oligonucleotides by the DNA polymerase (temperature for elongation 
depends on the polymerase used). Here DNA sequences for cloning were amplified 
using the KOD DNA polymerase with proofreading function. The following reaction mix 
for optimal performance of the polymerase was applied (all reagents were pipetted on 
ice): 
  DNA-template:   1 µg 
  dNTP-solution each 10 mM:  2 µL 
  5’ oligonucleotide:   20 pm 
  3’ oligonucleotide:   20 pm 
  5x KOD Buffer:   10 µL 
  DMSO:    1 µL 
  KOD-Polymerase:   1 µL 
  Aqua bidest:    ad 50 µL 
 
The following thermal cycler program was used for amplification of the template DNA: 
 
1. initial denaturation:  95°C  3 min. 
 2. denaturation:  95°C  45 sec. 
3. annealing:   40-65°C 45 sec. 
4. elongation:   72°C  1-2 min. 
5. repeat step 2 – 4 for 30 times 
6. final elongation:  72°C  10 min. 
7. cooling:   4°C  infinite 
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2.2.3.3 Agarose gel electrophoresis 
Agarose gel electrophoresis is an electrophoretic method for the separation of DNA 
fragments of differing lengths. DNA fragments are separated due to their negative 
charge and their size, as smaller pieces of DNA can migrate faster through the porous 
gel towards the anode than larger ones. Visualization of the DNA is enabled by the DNA 
intercalating dye SYBR® Safe DNA gel stain by InvitrogenTM, which is detectable under 
ultraviolet light. The agarose gel was cast using 1 % agarose in 1x TAE Buffer. The 
suspension was boiled until the agarose was completely resolved and poured into the 
casting chamber with the addition of 1 µL SYBR® Safe DNA gel stain. DNA samples 
were mixed with 6x sample buffer obtained from Thermo Scientific prior to loading to the 
gel. The DNA size marker 1kb GeneRulerTM DNA Ladder Mix from Thermo Scientific was 
used and agarose gels were run via application of 120 V for about 50 min. 
 
2.2.3.4 Restriction digest 
In order to clone a genetic sequence into a plasmid, insert DNA and plasmid need to be 
digested with the same restriction endonucleases. These enzymes create DNA 
overhangs which facilitate annealing of the insert DNA with the plasmid. By using two 
different restriction endonucleases on insert and plasmid, the right orientation of the 
insert in the finished plasmid is ensured. Cutting sites for the restriction endonucleases 
were integrated into the insert DNA via the oligonucleotides used in the PCR reaction to 
amplify the desired insert DNA. The digest of insert DNA and plasmid DNA was 
performed using the FastDigest restriction enzymes from Fermentas according to the 
protocol given by the manufacturer. The restriction digest reaction of plasmid DNA was 
additionally supplied with alkaline phosphatase which prevents religation of the plasmid 
DNA to itself. After the restriction digest, the obtained DNA fragments were purified via 
agarose gel extraction and their DNA concentration was measured with the 
NanoPhotometer®. 
 
2.2.3.5 Agarose Gel Extraction 
In order to extract DNA fragments previously separated by agarose gel electrophoresis 
for further processing, the agarose gel containing the separated samples was laid on a 
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UV-light table to visualize DNA. Desired DNA fragments were cut from the gel and 
transferred to reaction tubes followed by dissolving of the gel and purification of the DNA 
with the help of the NucleoSpin® Gel and PCR Clean-up Kit by Macherey-Nagel 
according to the manufacturers’ instructions. 
 
2.2.3.6 Ligation 
After digesting insert DNA and the plasmid backbone with the respective restriction 
enzymes, the generated fragments were ligated. For optimal ligation conditions, the ratio 
of insert to plasmid molar mass was 3:1. For exact calculation of the required amount of 
insert and plasmid DNA the following formula was applied: insert mass in ng = 3 x ( bp 
insert / bp plasmid ) x vector mass in ng. Next to the addition of insert and plasmid DNA, 
ligation reactions were supplied with T4-Ligase-Buffer and T4-Ligase obtained from 
Thermo Scientific according to the manufacturers protocol. Ligation reactions were 
pipetted on ice and incubated overnight at 16°C and slight shaking. After incubation, 12 
µL of the ligation reaction were given onto competent TG1 E. coli for transformation as 
described above. 
 
2.2.3.7 DNA Sequencing 
Sequence analysis of all cloned DNA constructs was performed by the company GATC 
Biotech AG. 
 
2.2.3.8 Quantitative real-time PCR (q-PCR) 
For quantification of protein transcripts via qRT-PCR, RNA was isolated from HeLa cells 
using the InviTrap® Spin Universal RNA Mini Kit from Stratec. With the 
NanoPhotometer® isolated RNA was analyzed for purity and the obtained concentration 
was determined. To prepare cDNA from RNA the iScript cDNA Synthesis-Kit from 
BioRad was used according to the manufacturers’ instructions. Here 0.5 µg of RNA were 
used per sample. For amplification and detection of PCR products during q-PCR the 
DNA intercalting dye EvaGreen-Kit was used according to the guidelines given by the 
manufacturer. As reference genes B2M and GAPDH were used. The qPCR was 
performed as follows: 
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cDNA-Synthesis: 
Reagent    Amount 
Isolated RNA    0.5 µg 
5’ Oligonucleotide   20 pm 
3’ Oligonucleotide   20 pm 
10 x iScript-Buffer   2 µL 
iScript-Polymerase   1 µL 
A. bidest    Ad 20 µL 
à cDNA was synthesized at 42°C for 45 min 
 
qPCR: 
Reagent    Amount 
cDNA     1 µL 
H2O     6.5 µL 
5’ Oligonucleotide   5 pm 
3’ oligonucleotide   5 pm 
EvaGreen Dye   6.5 µL 
A. bidest    15 µL 
 
 
qPCR programm: 
Phase     Temp.  Time 
1. Initial denaturation   97°C  3 min 
2. Denaturation   94°C  45 sec 
3. Annealing    68°C  30 sec 
4. Elongation    72°C  2 min 
5. Repeat phase 1. – 5 for 30 x 
6. Final elongation   72°C  7 min 
7. Denaturation   97°C  3 min 
8. Cooling     4°C  infinite 
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2.2.4 Methods in protein biochemistry 
 
2.2.4.1 Generation of crude extracts 
 Lysis buffer RIPA (+SDS):  25 mM Tris, pH 8 
      150 mM NaCl 
      0.1 % SDS 
      0.5 % Sodiumdeoxycholate 
      1 % Nonidet P-40 
      10 % Glycerol 
      2 mM EDTA 
      1 x “Complete” Protease inhibitor cocktail 
 SDS sample buffer (3x):  0.2 M Tris/HCl, pH 6.8 
      6 % SDS 
      30 % Glycerol 
      0.03 % Bromophenol blue 
      15 % β-Mercaptoethanol 
 
For analysis of cellular protein composition cells needed to be harvested and lysed. Cells 
were washed with PBS once prior to harvest. Cells were rubbed of the cell culture dish 
and suspended in PBS for transfer into a reaction tube. The cell suspension was 
centrifuged at 3500 rpm for 3 min and the supernatant was discarded. Depending on the 
cell pellet size, cells were resuspended in an appropriate amount of RIPA lysis buffer 
(ranging from 20 – 80 µL per cell pellet). The resuspended cells were incubated for 20 
min on ice to ensure sufficient lysis and centrifuged for 1 min at 10.000 rpm at 4°C to 
pellet residual cellular complexes. The supernatant containing the proteins for analysis 
was transferred into a new reaction tube and protein concentration was determined via 
Bradford test. Extracted protein solutions were adjusted to a working concentration of 4 
mg/mL via the addition of lysis buffer and three times concentrated SDS-sample buffer. 
For treatment with lambda phosphatase crude extracts were generated as described 
above. Lambda phosphatase was however added prior to adjustment of protein 
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concentration via the addition of 3x SDS-sample buffer. A detailed description of the 
lambda phosphatase assay is described below. 
 
2.2.4.2 Lambda Phosphatase assay 
For de-phosphorylation of proteins the lambda phosphatase from New England Biolabs 
was used. Here crude extracts were diluted with RIPA lysis buffer without the protease 
inhibitor cocktail to a working concentration of 6 µg / µL. 40 µL of crude extract were 
incubated with 5 µ L 10x Phosphatase Buffer, 5 µ L MnCl2 (10 mM) and 300 units 
lambda-phosphatase, for 30 min at 30°C. The reaction was stopped by the addition of 25 
µL 3x SDS-sample buffer with subsequent boiling of samples at 95°C for 5 min. Samples 
were analyzed via SDS-Gel electrophoresis and Western Blot. 
 
2.2.4.3 Discontinuous SDS-Page 
  running buffer:  25 mM Tris 
      190 mM Glycin 
      1 % SDS 
 
 Separation Gel:  
Gel concentration   7.5 %  10 %  12.5 %  15 % 
1.5 M Tris/HCl, pH 8.8:  1.52 mL 1.52 mL 1.52 mL 1.52 mL 
30 % Acrylamide (0.8 % BisAa.) 1.51 mL 20 mL  2.52 mL 3.02 mL 
dH2O     2.89 mL 24 mL  1.87 mL 1.37 mL 
10 % SDS    89 µL  89 µL  89 µL  89 µL 
10 % APS    39 µL  39 µL  39 µL  39 µL 
TEMED    4 µL  4 µL  4 µL  4 µL 
 
 Stacking Gel: 
1 M Tris/HCl, pH 6.5     400 µL 
30 % Acrylamide (0.8 % BisAa.)   266 µL 
dH2O       882 µL 
10 % SDS      48 µL 
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10 % APS      16 µL 
TEMED      1.6 µL 
 
SDS-Page (Sodium Dodecyl Sulfate Polyacrylamide gel electrophoresis) is an 
electrophoretic method to separate and visualize protein monomers according to their 
molecular weight. Proteins are denatured by heat in the presence of sodium dodecyl 
sulfate (SDS) which attaches to the resulting protein monomers, supplying them with a 
negative charge. Thereby the characteristic charge of each protein is overlayed. Once 
loaded to an SDS containing polyacrylamide gel the negatively charged protein 
monomers migrate through the gel by applying electricity. Their speed of migration is 
given by the molecular weight of the individual protein monomers. 30 – 50 µg of total 
protein per lane were loaded on SDS-Page gels and run at 20 mA for about 1.5 hours. 
Acrylamide percentage of the respective gel used and running time were dependent on 
the molecular weight of the protein to be analyzed. 
 
2.2.4.4 Coomassie staining 
  Coomassie solution:  50 % Methanol 
      10 % Acidic acid 
      0.125 % Coomassie Brillant Blue R 250 
  Destaining solution: 50 % Methanol 
      10 % Acidic acid 
 
For unspecific staining of proteins separated on an SDS-Page gel Coomassie Brillant 
Blue G-250 was used. The gel was incubated overnight in Coomassie solution at room 
temperature on a rocking platform. Background stain was removed via incubation of the 
gel in destaining solution twice for 30 min until only the stained protein bands were 
visible. 
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2.2.4.5 Western Blot 
 Transfer Buffer:   20 mM Tris 
      144 mM Glycine 
      20 % Methanol 
      0.01 % SDS 
TBST-Buffer:    20 mM Tris/HCl pH 7.6 
     137 mM NaCl 
     0.006 % Triton X-100 
Ponceau S solution:  5 % Albumin Fraction V/TBST 
      0.1 % Ponceau S 
5 % Acidic acid 
Blocking solution:   2% skim milk powder in TBST buffer 
 
The principle of Western Blots is based upon the transfer of proteins from a 
polyacrylamide gel onto a nitrocellulose membrane in an electric field. On this membrane 
the proteins of interest can be visualized with the help of protein specific antibodies. For 
the transfer an SDS-Page gel was placed onto a nitrocellulose membrane and 
embedded in WhatmanTM paper and sponges on each side. Blots were placed into a 
transfer buffer containing chamber and run at 300 mA for 90 min. The procedure was 
followed by staining of the nitrocellulose membrane with Panceau S solution to assess 
blotting efficiency. Membranes were washed with dH2O to remove the Panceau S stain 
and incubated for 30 min in 2 % skim milk containing TBST-Buffer (blocking solution) at 
room temperature. 
 
2.2.4.6 Immunodetection 
After blocking of the nitrocellulose membrane obtained from Western Blot (see above), 
primary antibody, specific for the protein to be analyzed, was added to the membrane. 
Antibodies used were previously diluted in blocking solution in a ratio of 1:250 up to 
1:2000, depending on the antibody used. The membrane was incubated with the primary 
antibody at 4°C overnight on a rocking platform. This was followed by three washing 
steps with TBST to remove residual primary antibody unbound to the membrane. After 
washing, the secondary, peroxidase coupled antibody was given onto the membrane at 
a 1:10000 dilution for 1 h at room temperature. The secondary antibody which was 
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applied was dependent on the species the primary antibody is derived from. After three 
additional TBST washing steps the bound antibodies were detected via a peroxidase 
mediated chemoluminescence reaction. This was achieved by the use of ECL-solution 
applied according to the instructions given by the manufacturer. In a dark room X-ray 
films were laid on top of the membrane for exposure of differing lengths (depending on 
the efficacy of the primary antibody and abundance of the protein to be detected). X-ray 
films were developed in an automated developing machine. 
 
2.2.4.7 Bradford protein assay 
For determination of protein concentration the Bradford protein assay was applied. With 
Coomassie Brilliant Blue G-250 proteins from complexes which can be measured in a 
photometer. Under normal conditions Coomassie Brilliant Blue G-250 has an absorption 
maximum at 470 nm. In complex with proteins this absorption maximum is shifted to 595 
nm which can be used as basis for measurement. Prior to measurement of protein 
sample concentration, the photometer was calibrated with a γ-Globuline standard. For 
the measurement 1 µL of protein sample was given to 1 mL Bradford solution and mixed 
thoroughly. After 10 min incubation at room temperature the Bradford-sample mix was 
given into a plastic cuvette for measurement. 1 mL of Bradford-solution was taken as 
blank. 
 
2.2.4.8 TCA protein precipitation 
For concnetration of protein samples they were precipitated using trichloroacetic acid 
(TCA). Samples were treated with a final TCA concentration of 12.5 % and incubated for 
at least 1 h on ice, followed by 30 min centrifugation at 20.000 g and 4°C. The TCA 
containing supernatant was completely removed from the sample and the precipitated 
protein pellet was resusupended in SDS sample buffer. If necessary, acidic pH was 
neutralized via the addition of 1 – 2 µL 1 M Tris pH 9.0 prior to boiling the sample at 95°C 
for 5 min. 
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2.2.4.9 Immunoprecipitation 
 RIPA Lysis buffer (without SDS):  25 mM Tris, pH 8.0 
       150 mM NaCl 
       0.5 % Sodiumdeoxycholate 
       1 % Nonidet P-40 
       10 % Glycerol 
       2 mM EDTA 
       1 x “Complete” Protease inhibitor 
cocktail 
 MOPS/KCl washing buffer:   20 mM MOPS, pH 7.2 
       100 mM KCl 
 Elution buffer:    0.1 M Glycine / HCl, pH 3.5 
 
Immunoprecipitation is used for isolation of protein complexes bound to a protein of 
interest. 4 x 10 cm cell culture dishes of HeLa cells were harvested and lysed with RIPA 
lysis buffer (without SDS) for 30 min on ice. After that, crude extracts were shortly 
ultrasonicated (2 x 10 sec) followed by 20 min centrifugation at 16.000 g and 4°C. The 
supernatant containing the proteins was diluted to a working concentration of 8 µg / µL 
with MOPS/KCl buffer. For immunoprecipitation of overexpressed proteins containing a 
FLAG-tag M2 sepharose was used, to which the FLAG.tag can bind directly. For 
immunoprecipitation under endogenous conditions protein-G sepharose, together with a 
specific antibody for the protein to be analyzed was used. Here the antibody heavy chain 
can bind to the protein-G covered beads. M2 sepharose and protein-G sepharose were 
equilibrated with 3 RIPA washing steps before usage in immunoprecipitation. Protein 
extracts for analysis were incubated with M2 sepharose or protein-G sepharose and 
antibody for 3 h at 4°C on a rotating wheel. After incubation the samples were washed 3 
x with 1 mL RIPA washing buffer (without SDS) and 3 x with 1 mL MOPS/KCl buffer. 
Then bound protein complexes were eluted from the sepharose beads via the addition of 
1 mL elution buffer and 12 min incubation on ice. The eluted protein complexes were 
precipitated by the addition of TCA as described above. Isolated protein complexes were 
analyzed via SDS-Page and Western Blot. 
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2.2.4.10 Mass Spectrometry 
For identification of novel interaction partners of SYNPO mass spectrometry via MALDI-
TOF (matrix assisited laser desorption ionization – time of flight) was performed by the 
Proteomics Facility of the Center for Molecular Medicine Cologne (http://cecad.uni-
koeln.de/Services.274.0.html). For sample preparation an immunoprecipitation 
experiment was performed as described above with an additional elution step using ATP. 
Obtained protein complexes were separated using a 12.5 % acrylamide gel in SDS-Page 
followed by Coomassie staining of the gel. Prominent bands visualized via Coomassie 
staining were cut from the gel, transferred into a reaction tube and sent to Cologne. 
Peptide data obtained from mass spectrometry was aligned to the UniProt database. 
 
 
 
2.2.5 Methods in Cell biology 
 
2.2.5.1 Immunofluorescence 
PBS:    137 mM NaCl 
2.7 mM KCl 
8 mM Na2HPO4 
1.4 mM KH2PO4 
pH 7.4 
 
 Quenching-Solution   50 mM NH4Cl 
 Blocking Solution   3 % BSA in PBS 
 
HeLa cells were seeded out in 24 well plates equipped with round glass cover slips. For 
immunofluorescent staining cells were washed twice with PBS and fixed with 4 % 
paraformaldehyde in PBS for 12 min at room temperature. After three washing steps with 
PBS cells were permeabilzed via addition of 0.2 % Triton-X 100 in PBS for 12 min at 
room temperature. After additional three washing steps quenching-solution was applied 
for 30 min only for cells that were used for EEA1 staining. For all other antibodies used 
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for staining, cells were directly blocked with blocking solution for 1 h after washing with 
PBS. Antibodies were diluted according to manufacturers’ guidelines in blocking solution 
and cells were incubated with the respective antibody for at least 1 h at room 
temperature. For EEA1 staining the antibody solution was incubated with the cells in a 
humidity chamber at 4°C overnight. Incubation with the primary antibody was followed by 
three subsequent PBS washing steps before the secondary antibody could be applied. 
Secondary antibodies were diluted 1:400 in blocking solution and incubated with the cells 
for 1 up to 4 h. Cells were again washed three times with PBS and shortly dipped in A. 
bidest to remove residual salts from PBS before mounting with MOWIOL®. Samples 
were left at a dark place at room temperature overnight for the mounting medium to dry 
before analysis with the microscope. 
 
 
2.2.6 Statistics 
Significance was calculated using the students T-Test in Excel. Each experiment was 
performed independently for at least three times (n). Western Blots were quantified using 
the software ImageJ. For immunofluorescence the LSM image browser was used. 
Strategies for cloning of plasmids were tested with the software GENtle. 
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3. Results 
 
3.1 SYNPO2 is not expressed in HeLa cells 
Previously published findings link BAG3 to the SYNPO family of proteins via an 
interaction of BAG3 with SYNPO2 in the context of mechanotransduction in muscle and 
immune cells (Ulbricht et al. 2013). Besides SYNPO2, a peptide screen consisting of 
proline-rich peptides, performed to identify novel interactors of the BAG3 WW-domain, 
also identified SYNPO as a binding partner of BAG3 (PhD thesis Ulbricht 2013, 
unpublished data). As SYNPO2 expression shows tissue specificity to muscle cells, the 
immune system, prostate, colon and small intestine (Lin et al. 2001), the closely related 
protein SYNPO was hypothesized to take on a comparable role to SYNPO2 function in 
CASA in cells that do not express SYNPO2. In order to find a cell line which lacks 
SYNPO2 but expresses SYNPO, crude extracts of five different cell lines were tested for 
SYNPO2 and SYNPO expression. As can be seen in figure 3.1 (A) SYNPO2 is 
expressed in A7r5 (Rattus norvegicus, smooth muscle) and SH-SY5Y (Homo sapiens, 
neuroblasts from neural tissue) cells lines. SYNPO expression can be detected in all cell 
lines tested namely A7r5, Hek-293 (Homo sapiens, embryonic kidney), HeLa (Homo 
sapiens, cervical cancer), MEF (Mus musculus, embryonic fibroblasts) and SH-SY5Y 
(figure 3.1 (B)). HeLa cells were chosen for the analysis of SYNPO in the context of 
CASA, as they do not express SYNPO2 but show SYNPO expression. 
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Figure 3.1: Expression of SYNPO2 and SYNPO in various cell lines of mammalian 
origin. SYNPO2 is detectable in A7r5 and SH-SY5Y cells (A) whereas SYNPO 
expression can be detected in crude extracts of all cell lines tested. The most prominent 
band detected by the antibody against SYNPO manifests itself at a size of 130 kDa. 40 
µg of protein were loaded for each lane. 
 
 
3.2 SYNPO is a novel interactor of BAG3 
SYNPO2 and SYNPO share a 35 % sequence homology using the Basic Local 
Alignment Search Tool (BLAST) (https://blast.ncbi.nlm.nih.gov/Blast.cgi). Additionally 
both proteins could be identified as interactors of the BAG3 WW-domain in a peptide 
screen (PhD thesis Ulbricht 2013, unpublished data), and both proteins contain at least 
one centrally located PPXY motif (Ulbricht et al. 2013) (figure 3.2). To test for a potential 
interaction of endogenously expressed BAG3 and SYNPO, co-immunoprecipitation 
experiments were performed using HeLa cells, showing that indeed BAG3 can co-
precipitate in a complex with the 130 kDa isoform(s) of SYNPO (SYNPOa/c) (figure 3.2). 
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Figure 3.2: SYNPO interacts with BAG3. SYNPO complexes were pulled down with an 
antibody specific for SYNPO. Western blot analysis shows the presence of BAG3 in 
these SYNPO complexes isolated from HeLa crude extracts. 32 µg protein were loaded 
of the extract (left lane). 1/3 of total eluate was loaded for the IgG controls and the 
specific IPs respectively. 
 
 
3.3 SYNPO in Homo sapiens 
The human gene for SYNPO is located on chromosome 5, q33.1, has a size of 58.140 
bp and comprises, depending on the isoform, three exons (two coding exons) and two 
introns. Three different genetic isoforms of SYNPO can be expressed, giving rise to 
three different isoforms of the translated protein (figure 3.3). The three isoforms of 
SYNPO are identical in their central sequence but differ in their respective N- or C-
termini and in their predicted molecular weights which lie at 74 kDa for the shortest 
SYNPO isoform: SYNPOb, 96 kDa for the intermediate isoform: SYNPOa and 99 kDa for 
the longest SYNPO isoform: SYNPOc. 
 
 
Figure 3.3: Schematic representation of the three isoforms of human SYNPO 
protein. Motifs and binding sites are marked in color. Furthermore the immunogen of the 
antibody used in this work is marked as a grey box. All three isoforms contain two 
subsequent PPXY motifs located in the center of the protein. Additionally two CatL 
cleavage sites (marked in green) and two binding sites for 14-3-3 protein can be found in 
each isoform. SYNPOc has an LPPPP motif at its N-terminus whereas SYNPOa. 
contains a C-terminally located LPPPP and PPXXF motif. 
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3.4 Analysis of SYNPO in HeLa cells 
A general overview of SYNPO expression in five different mammalian cell lines could 
already be seen in figure 3.1. A clear discrepancy in the size of the detected bands by 
the SYNPO antibody (prominent band at 130 kDa) and the predicted molecular weight 
between 74 to 99 kDa (figure 3.3) can be observed. In order to verify that the detected 
bands in figure 3.1 are indeed SYNPO isoforms, FLAG-Tag expression constructs have 
been cloned for overexpression of SYNPOb and SYNPOc. Overexpression of the short 
isoform of SYNPO could be detected at 100 kDa (figure 3.4 (A)). The distinctive band 
seen in figure 3.3 at approximately 130 kDa could be identified as SYNPOc as shown in 
figure 3.4 (B). A functional overexpression construct for SYNPOa could not be generated 
in the course of this work. This leaves the question of the molecular weight and migration 
behavior of SYNPOa in HeLa cells unanswered. Importantly, due to only slight 
differences in amino acid number between SYNPOa (903 aa) and SYNPOc (929 aa), it 
cannot be excluded, that SYNPOa might run at roughly the same height as SYNPOc 
(130 kDa) in an SDS-page gel. Therefore the 130 kDa SYNPO band is designated as 
SYNPOa/c if not stated otherwise. 
Next to SYNPO isoform characterization, the impact of SYNPOb / SYNPOc 
overexpression on the cellular concentration of BAG3 was investigated, revealing no 
changes in BAG3 protein levels for SYNPOb overexpression but a significant increase of 
BAG3 upon SYNPOc overexpression. 
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Figure 3.4: Overexpression of SYNPOb and SYNPOc. HeLa cells were transfected 
with the expression constructs pCMV2b-SYNPOb (A) and pCMV2b-SYNPOc (B) 
respectively and incubated for 48 h. Crude extracts were analyzed by Western blot, 
showing that SYNPOb appears at a size of 100 kDa (A) whereas SYNPOc runs slightly 
above 130 kDa (B). Overexpression of SYNPOb leaves detectable BAG3 unaffected (A) 
whereas BAG3 protein levels are increased upon overexpression of SYNPOc (B). Each 
lane was loaded with 40 µg of total protein. 
 
Furthermore, it was investigated whether depletion of the SYNPO isoforms by using 
specific siRNAs can abrogate the detected SYNPO signals at 130 and 100 kDa. This 
was indeed the case, confirming the specificity of the used antibody. It was also 
investigated whether this depletion of SYNPO affects BAG3 protein levels. As depicted 
in figure 3.5 simultaneous knockdown of SYNPO isoforms did not affect BAG3 protein 
levels. 
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Figure 3.5: Knockdown of SYNPO isoforms by specific siRNAs. HeLa cells were 
transfected with specific siRNA against SYNPO for 48 h prior to harvest. It can be 
observed that detectable SYNPO signals at 130 and 100 kDa are highly diminished, 
whereas BAG3 remains unchanged upon depletion of SYNPO in HeLa cells. 40 µg of 
protein were loaded for each lane. 
 
A previous report by Faul et al. (2008) shows that SYNPO contains two prominent CatL 
cleavage sites indicated in green in figure 3.2. Indeed the authors could show that 
SYNPO is cleaved by CatL in podocytes resulting in a 44 kDa SYNPO fragment. To test 
whether SYNPO is also cleaved by CatL in HeLa cells, E64d, a specific inhibitor of CatL 
was employed. Administration of E64d did not alter SYNPO protein levels in HeLa cells 
(quantified for SYNPOa/c) (figure 3.6). Furthermore it is of note that the 44 kDa SYNPO 
fragment resulting from proteolytic cleavage by CatL could not be detected in any 
experiments performed for this work. 
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Figure 3.6: SYNPO is not cleaved by CatL in HeLa cells. HeLa cells were treated with 
E64d for 16 h overnight prior to cell lysis. SYNPOa/c protein levels remain unaffected by 
E64d treatment visualized by the diagram. Weak signals for SYNPOb at approximately 
100 kDa and no band at 44 kDa could be observed (44 kDa is the expected cleavage 
product of SYNPO in podocytes (Faul et al. 2008)). 40 µ g of protein were loaded for 
each lane. 
 
 
3.5 SYNPOa/c shows an upward shift in Western blots 
upon proteasome inhibition 
Because SYNPO2 is degraded quickly via autophagy upon mechanical strain, it should 
be assessed whether inhibition of the proteasome (induction of autophagy), by MG132 
treatment, or the inhibition of the autophagy-lysosomal pathway (induction of 
proteasomal degradation of proteins), by BafA1 treatment, has any effect on SYNPO. As 
shown in figure 3.7 treatment of HeLa cells with the respective inhibitors does not show a 
significant change of SYNPOb levels (figure 3.7 A). For SYNPOa/c there is a shift in size 
upon proteasomal inhibition via MG132, which is quantified in the upper right (upper 
band) and lower right (lower band) panel (figure 3.7 B). In regards of degradation or 
stabilization the inhibitors do not show an effect on SYNPOa/c. 
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Figure 3.7: Inhibition of protein degradation pathways and shift in size of 
SYNPOa/c. HeLa cells were treated, for 16 h prior to harvest, with either DMSO as 
control, MG132 (proteasome inhibition) or BafA1 (inhibitor of autophagy). SYNPOb 
shows great variation in protein stability upon treatment with the respective inhibitors (A). 
SYNPOa/c protein neither gets stabilized nor degraded by the application of either of the 
two inhibitors. However a shift to a higher molecular weight band of SYNPOa/c can be 
observed when treating cells with MG132 or a combination of MG132 and BafA1 (B). 
Separate quantification of the two SYNPOa/c bands observed is shown in the two 
diagrams on the right. 40 µg of protein were loaded for each lane. 
 
 
3.6 SYNPOa/c is phosphorylated in vivo 
When regarding the long isoform of SYNPO in HeLa cells, two distinct bands can be 
observed at approximately 130 kDa in height, as shown above in figure 3.3. Additionally 
a shift to the upper band of SYNPOa/c can be induced by MG132 treatment of the cells 
(figure 3.7). This phenomenon gives rise to the question whether SYNPOa/c is post-
translationally modified and therefore shows a second band of slightly higher molecular 
weight in Western Blot experiments. To elucidate the nature of the upper SYNPOa/c 
band, a Lambda Protein Phosphatase (λPP) assay was performed. The data 
demonstrate that SYNPOa/c is phosphorylated in vivo (figure 3.8). Overnight treatment 
of HeLa cells with MG132 shows the previously observed effect of a shift of the 
SYNPOa/c band to a higher molecular weight with no effect on the total SYNPOa/c 
protein level (figure 3.7). λPP treatment efficiently diminished the upper band signal of 
SYNPOa/c also for the MG132 treated samples (figure 3.8). 
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Figure 3.8: 130 kDa SYNPOa/c is phosphorylated. HeLa cells were treated with 
DMSO or MG132 for 16 h prior to harvest. Crude extracts were subjected to incubation 
with Lambda Protein Phosphatase (λPP) for 0 min (control, t0) and 30 min (t30) at 30°C. 
S6-P, an antibody detecting solely the phosphorylated form of S6 protein serves as a 
control for protein dephosphorylation. The shift of the SYNPOa/c band upon MG132 
treatment can be clearly observed, whereas total protein amount remains constant, 
regardless of the treatment (left panel). Incubation with λPP attenuates the Western Blot 
signal for the phosphorylated form of SYNPOa/c, quantified in the upper right panel. λPP 
treatment has no effect on the amount of native, unphosphorylated SYNPOa/c 
(SYNPOa/c w/o p), (lower right panel). 40 µg of protein were loaded for each lane. 
 
 
3.7 BAG3 as an effector of SYNPO 
It was further assessed whether altered BAG3 protein expression has any impact on 
SYNPO protein levels. This was monitored by either overexpression or siRNA mediated 
knockdown of BAG3 in HeLa cells. Overexpression of BAG3 shows a stabilizing effect 
on SYNPO (figure 3.9 A), whereas BAG3 depletion has the no significant effect on 
SYNPO protein levels (figure 3.9 B). 
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Figure 3.9: SYNPOa/c protein levels upon alterations in BAG3 expression. (A) HeLa 
cells were transfected with pcDNA-BAG3 and the respective control plasmid pcDNA-
empty (48 h). A clear stabilization of SYNPOa/c protein can be observed when 
increasing BAG3 expression. (B) HeLa cells were transfected with siRNA against BAG3 
for 24 h, then a re-transfection was performed for additional 48 h. Depletion of BAG3 
shows a minor, but not significant, decrease in SYNPOa/c protein levels. 40 µg of protein 
were loaded for each lane. It is of note, that SYNPOb appears to be stabilized by BAG3 
overexpression as well (A) but was not quantified in the context of this work. 
 
 
3.8 BAG3 – SYNPOc interaction depends on BAG3 WW-
domain and SYNPOc PPXY motifs 
As could be established in the beginning endogenous BAG3 and SYNPOa/c can be co-
immunoprecipitated (figure 3.1). In order to confirm whether this interaction is mediated 
via an interaction of SYNPO PPXY-motifs with the WW-domain of BAG3 (as it is for 
BAG3 and SYNPO2 (Ulbricht et al. 2013)), mutant forms of SYNPOc and BAG3, 
equipped with a FLAG-Tag, were used. In detail, the BAG3 mutant used (pCMV2b-
BAG3-WAWA, W26A, W48A) contains a non-functional WW-domain. In addition three 
different SYNPOc mutants were employed. The first SYNPOc mutant has a double 
amino acid substitution in the first PPXY motif: P610A and T611A further designated as 
pCMV2b-SYNPOc-PAAY1st. The second mutant contains a double mutation within the 
second PPXY-motif of SYNPOc (P629A, S630A), titled pCMV2b-SYNPOc-PAAY2nd. The 
third and last SYNPOc mutant is a double mutant of both PPXY motifs simultaneously, 
pCMV2b-SYNPOc-PAAYdouble. It could be shown that the interaction of SYNPO and 
BAG3 is clearly dependent on a functional WW-domain of BAG3 and intact PPXY motifs 
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on the side of SYNPOc (figure 3.10). pCMV2b-SYNPOc-PAAY1st is still fully able to bind 
BAG3, as bound BAG3 amounts are comparable to the wildtype control. For pCMV2b-
SYNPOc-PAAY2nd binding of BAG3 is highly diminished whereas pCMV2b-SYNPOc-
PAAYdouble shows only very slight residual binding of BAG3 (figure 3.10 A). Vice versa it 
can be observed that SYNPO – BAG3 interaction is abrogated by employing FLAG-
BAG3-WAWA in an IP experiment. In addition it can be observed that overexpressed 
BAG3 wildtype is able to bind to SYNPOa/c w/o p, p-SYNPOa/c as well as to SYNPOb 
(figure 3.10). 
 
 
Figure 3.10: SYNPOc – BAG3 interaction is dependent on SYNPOc PPXY motifs 
and BAG3 WW-domain. HeLa cells were transfected with FLAG-tagged mutant forms of 
SYNPOc (A) or mutant BAG3 (B) for 48 h prior to harvest. Cell extracts were subjected 
to IP directed against the FLAG-epitope of the overexpressed constructs. Mutation of 
SYNPOc-PPXY motifs abrogates BAG3 binding to SYNPOc (A). Additionally SYNPOc – 
BAG3 interaction is abolished upon mutation of BAG3 WW-domain (B). Furthermore 
BAG3 wildtype shows binding to SYNPOa/c w/o p, p-SYNPOa/c and SYNPOb (B). 32 µg 
of protein was loaded per lane for all extract samples. 1/3 of the total eluate from the 
FLAG-IPs was applied per lane. 
 
Immunofluorescence experiments were performed to analyze the localization of SYNPO 
and the impact of BAG3 on this. Additionally, the binding of SYNPOc and BAG3 and the 
dependency on SYNPOc PPXY motifs should be confirmed using a different 
experimental approach. As expected co-localization of SYNPOc and BAG3 is no longer 
detectable when co-expressing pCMV2b-SYNPOc-PAAYdouble together with pEGFP-BAG3. 
Interestingly overexpressed SYNPOc wildtype as well as pCMV2b-SYNPOc-PAAYdouble 
localize into punctate structures (figure 3.11). This punctate pattern of SYNPO has been 
described previously (Mundel et al. 1997), however the molecular characteristics of 
these SYNPO punctae have thus far not been elucidated. Next to the loss of SYNPOc – 
BAG3 co-localization upon overexpression of pCMV2b-SYNPOc-PAAYdouble it is of 
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interest, that BAG3 overexpression alone (figure 3.11, left panel) is not sufficient to show 
a punctate pattern of BAG3 protein. Only in combination with SYNPOc overexpression 
does BAG3 co-localize to the SYNPOc punctae which suggests an active recruitment of 
BAG3 by SYNPOc to these punctae (figure 3.11 3rd panel). 
 
 
Figure 3.11: SYNPOc PPXY motifs are crucial for SYNPOc – BAG3 co-localization. 
HeLa cells were transfected with either pEGFP-empty, pEGFP-BAG3, pCMV2b-
SYNPOc or pCMV2b-SYNPOc-PAAYdouble for 48 h. SYNPOc – BAG3 co-localization is 
lost upon overexpression of pCMV2b-SYNPOc-PAAYdouble. SYNPOc wildtype as well as 
SYNPOc-PAAYdouble appear in punctate structures. White bars correspond to 20 µm. 
 
 
3.9 General assessment of SYNPOc punctae 
Accumulation of SYNPOc in dot-like structures directly evokes the question of the 
molecular character of these SYNPOc punctae. As described above the punctate pattern 
of SYNPO has been observed previously and could be shown to co-localize to actin 
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(Mundel at al. 1997). However further characteristics of these SYNPO punctae remain to 
be elucidated. Asanuma et al. (2005) describe SYNPO punctae in podocytes to be 
amorphous, cytoplasmic, phalloidin-positive aggregates. In HeLa cells (used in this work) 
overexpression of SYNPOc results in similar punctae morphology, however the punctae 
observed appear to be rather round with a large proportion of them showing small 
pointed protrusions (figure 3.12). 
 
 
Figure 3.12: SYNPOc punctae in HeLa cells. HeLa cells were transfected with pCMV-
empty (control) or pCMV-SYNPOc for 48 hours prior to immunostaining procedure. 
Endogenous SYNPO is evenly distributed throughout the cytoplasm in control cells 
forming few small punctae indicated by white arrows (1st panel from the left). Upon 
overexpression, SYNPOc accumulates in large punctae which are distributed throughout 
the cytoplasm (panels 2, 3 and 4) Many punctae show small pointed protrusions marked 
by white arrows (2nd panel). Some cells overexpressing SYNPOc show, next to SYNPOc 
punctae, thick stress fibers (3rd panel). Additionally ring like SYNPOc punctae can be 
frequently observed (4th panel). Bottom pictures represent a 5x magnification of the area 
marked by the white box in the upper panel. The white bars equal 20 µm. 
 
To shed light into the potential function of SYNPOc punctae, several markers of different 
cellular pathways and structures were employed. Markers for autophagy (p62 and LC3), 
lysosomes (LAMP-1), aggresomes (vimentin), ubiquitin (FK2) and the cytoskeleton (actin 
and tubulin) have been subjected to immunofluorescent staining of HeLa cells 
transfected with pCMV2b-SYNPOc as shown in figure 3.13. It can be seen, that the 
SYNPOc punctae show neither co-staining for p62, LC3, LAMP-1, vimentin (VIM), FK2 
nor tubulin. Staining of the actin cytoskeleton via phalloidin however confirms the 
previously described (Mundel et al. 1997) co-localization of F-actin with SYNPO punctae. 
58  Results 
______________________________________________________________________ 
 
 
Figure 3.13: SYNPOc punctae in combination with various molecular markers. 
HeLa cells have been transfected with pCMV2b-SYNPOc and other plasmids as 
indicated above the respective panels for 48 h. SYNPOc punctae do not associate with 
p62 and LC3 (autophagy), LAMP-1 (lysosomes), vimentin (aggresomes), FK2 (ubiquitin) 
nor γ-tubulin. A co-localization of SYNPOc punctae can solely be observed with the actin 
cytoskeleton as shown in the right most panel. White bars equal 20 µm. 
 
In addition to immunofluorescence experiments (figure 3.13) co-immunoprecipitation was 
performed in order to confirm the previously described binding of SYNPO to actin. As 
expected β-actin co-precipitates with SYNPO as depicted in figure 3.14. 
 
 
Figure 3.14: IP of SYNPO validating its interaction with actin. SYNPO complexes 
were pulled down from HeLa cell crude extracts using a specific antibody against 
SYNPO. It can be seen that β-actin co-precipitates with SYNPO as shown by a specific 
band for β-actin in the Western blot. 32 µg protein were loaded of the extract (left lane). 
1/3 of total eluate was loaded for the IgG controls and the specific IP respectively. 
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3.10 SYNPOc punctae co-localize with the endosomal 
marker EEA1 
As shown above in figure 3.13, SYNPOc punctae fail to co-localize with molecular 
markers for autophagosomes, lysosomes, aggresomes and microtubule. As established 
in figure 3.12, SYNPOc punctae were observed to form ring like structures. Fratti et al. 
(2001) show that the endosomal marker Early Endosome Antigen 1 (EEA1) also appears 
in ring-like structures upon immunofluorescent staining in murine macrophages. 
Therefore EEA1 was tested for co-localization to SYNPOc punctae. As depicted in figure 
3.15 SYNPOc punctae co-localize with early endosomes under endogenous conditions 
(left panels) as well as upon overexpression of SYNPOc (right panels). 
 
Figure 3.15: SYNPO punctae co-localize with EEA1. HeLa cells have been 
transfected with pCMV-empty (panels 1-3) and pCMV-SYNPOc (panels 4-6). The 
endosomal marker protein EEA1 co-localizes with SYNPO punctae under endogenous 
conditions (panel 1-3) and upon overexpression of SYNPOc (panel 4-6). SYNPOc ring 
like structures are positive for EEA1. Lower panels represent a 5x magnification of the 
area marked by the white box. White bars equal 20 µm. 
 
 
3.11 Identification of novel SYNPO binding partners via 
mass spectrometry 
For further elucidation of the molecular function of SYNPO and in order to identify 
binding partners aiding the characterization of SYNPOc punctae, IP for SYNPO with 
subsequent peptide analysis via mass spectrometry was performed. Proteins which co-
precipitated with SYNPO were either eluted via addition of glycine buffer or incubation 
with ATP. Total eluates were separated via SDS-gel electrophoresis and stained by 
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Coomassie brilliant blue. Prominent bands, as depicted in figure 3.16 were cut from the 
gel and sent to analysis via mass spectrometry. Obtained peptide data was run against 
the protein database UniProt and a total of 100 potential binding partners of SYNPO 
could be identified. These have been further narrowed down by their score parameter 
and their relevance for cytoskeletal dynamics or connection to cellular vesicles or BAG3 
(table 3.1). 
 
Figure 3.16: SDS-gels of SYNPO IP for mass spectrometry. HeLa cell crude extract 
was subjected to IP of SYNPO. Elution was either performed by addition of glycine (left 
panel) or ATP (right panel). Red bars point out bands which were cut from the gel for 
analysis via mass spectrometry. For identification each band was assigned a number, 
also given in red, next to the bars.  
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Table 3.1: Potential SYNPO binding partners identified via mass spectrometry: 
From total data obtained by mass spectrometry this list of potential SYNPO binding 
partners was generated. Parameters were the protein score and a link to cytoskeletal 
functions / dynamics, cellular vesicles or BAG3. It is of note that roughly 25 % of the 
identified potential SYNPO binding partners are associated with mRNA processing 
according to literature (data not included in the table). 
Abbreviation Full name Score kDa band 
# 
Actb Actin, cytoplasmic 1 1017,5 42 5 
Actg1 Actin, cytoplasmic 2 872,35 42 5 
Aldoa Fructose-biphosphate aldolase A 303,95 39 6 
ANXA1 Annexin A1 516,38 39 7 
ANXA2 Annexin A2 792,4 39 7 
ANXA3 Annexin A3 298,87 36 7 
ANXA5 Annexin A5 588,34 36 7 
Capza1 F-actin-capping protein subunit alpha-1 174,6 33 6 
Capza2 F-actin-capping protein subunit alpha-2 149,21 33 7 
Chmp4b Charged multivesicular body protein 114,38 25 7 
Fscn1 Fascin 169,61 55 4 
Gapdh Glyceraldehyde-3-phosphate dehydrogenase 422,28 36 6 
Hspa8 Heat shock cognate 71 kDa protein 1043,03 71 1 
Hspa9 Stress-70 protein, mitochondrial 564,31 73 1 
Pdlim1 PDZ and LIM domain protein 1 351,92 36 6 
Tpm1 Tropomyosin alpha-1 chain 1551,2 33 7 
VIM Vimentin  1937,18 
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3.12 Validation of potential SYNPO binding partners 
obtained via mass spectrometry 
As expected, various components of the actin cytoskeleton were identified as potential 
binding partners of SYNPO in mass spectrometry (table 3.1). Especially Annexin A2 
(ANXA2) was of interest as it has been previously described to function in vesicle 
formation and autophagy (Moreau et al. 2015, Morozova et al. 2015). Surprisingly 
vimentin (VIM) was also identified as a putative binding partner of SYNPO by mass 
spectrometry (table 3.1) opposing the data obtained from immunofluorescence 
experiments shown above in figure 3.13 in which co-localization of SYNPOc with 
vimentin could not be observed. For clarification a FLAG-tagged overexpression 
construct of vimentin (pCMV2b-Vim) was generated and used in an IP directed against 
the FLAG-epitope of overexpressed vimentin. The same experiment was performed 
using an overexpression construct for Annexin A2 (pCMV2b-ANXA2). Both, Annexin A2 
and vimentin were able to co-precipitate SYNPOa/c. Additionally BAG3 could be 
detected in the precipitate of ANXA2 complexes (figure 3.17). 
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Figure 3.17: Annexin A2 and vimentin bind SYNPO. HeLa cells were transfected with 
either pCMV2b-ANXA2 or pCMV2b-VIM for 48 h. IP was directed against the FLAG-
epitope of the overexpressed proteins. Annexin A2 as well as vimentin are able to co-
precipitate SYNPO. Annexin A2 additionally co-precipitates BAG3. 32 µ g protein was 
loaded of the extract (left lanes). 1/3 of total eluate was loaded for the negative controls 
and the specific IPs respectively.
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4. Discussion 
The co-chaperone BAG3 has been shown to be involved in essential cellular processes 
such as apoptosis (Lee at al. 1999, Zhang et al. 2012), cell migration, actin cytoskeleton 
dynamics (Iwasaki et al. 2007), autophagy (Arndt et al. 2010, Ulbricht et al. 2013), 
proteostasis and transcriptional processes (Ulbricht et al. 2013). Being such a versatile 
protein, it will be important to elucidate the BAG3 interactome and its various functions 
depending on cell type and context. This is also of pathological relevance as mutations in 
the human BAG3 gene are associated with severe myopathies (Villard et al. 2011, 
Kostera-Pruszczyk et al. 2015). In this work the actin binding protein SYNPO could be 
identified as a novel binding partner of BAG3. Whereas the SYNPO family member 
SYNPO2 cooperates with BAG3 during autophagy in muscle and immune cells (Ulbricht 
et al. 2013), SYNPO does apparently not fulfill degradative functions in HeLa cells under 
the experimental conditions used. SYNPOc localizes to punctate, actin-containing 
assemblies to which BAG3 is recruited. It could be shown in HeLa cells that SYNPOc co-
localizes with early endosomes, implicating a possible involvement of SYNPOc in the 
transport or processing of endocytic vesicles. In addition, many new putative binding 
partners of the SYNPO – BAG3 complex could be identified in the context of this work, of 
which Annexin A2 could be shown to interact with BAG3 and SYNPO in vivo. Due to its 
role in endosomal transport (Mayran et al. 2003, Morel et al. 2009), identification of 
Annexin A2 supports the possible involvement of SYNPOc and BAG3 in endosomal 
transport or processing. 
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4.1 SYNPO, a novel BAG3 binding partner 
The actin binding protein SYNPO could be identified as a novel interactor of BAG3 in 
HeLa cells (figure 3.2). Thus far most of the published data concerning SYNPO is 
derived from experiments on kidney podocytes and neuronal cells (Mundel et al. 1991 
and 1997, Deller et al. 2003, Schiewek et al. 2004, Asanuma et al. 2006). For a more 
general assessment of SYNPO expression crude extracts derived from several human 
and murine cell lines were tested for the presence of SYNPO. In kidney podocytes 
Mundel et al. (1991 and 1997) observed a SYNPO band with the size of 110 kDa with an 
additional proteolytic fragment of 44 kDa. In extracts from rat forebrain SYNPO is 
detectable at 100 kDa (Mundel et al. 1997). In this work all cell lines tested show most 
prominent SYNPO bands at a size of approximately 130 kDa. Additionally a band at 100 
kDa can be observed for all five cell lines. Next to unique bands at various heights for the 
respective cell lines no band can be seen at 44 kDa (figure 3.1). This is surprising as one 
would expect a band at 110 kDa especially for the Hek-293 extract as this cell line is 
derived from human embryonic kidney cells. However, the cell extracts revealing a band 
at 110 kDa and the proteolytic cleavage product at 44 kDa described by Mundel et al. 
(1991 and 1997) are derived from kidney podocytes which is a highly specialized cell 
type exclusive to the glomeruli of the kidney (reviewed by Pavenstädt, 2000). This 
specialization might explain the difference in the detected bands for SYNPO, as 
podocyte SYNPO might undergo different posttranslational processing than in other cell 
types, or even more likely SYNPO isoforms may be differentially expressed depending 
on the cell type. Research of the NCBI and UniProt database 
(https://www.ncbi.nlm.nih.gov, http://www.uniprot.org/) revealed a total of three SYNPO 
isoforms, SYNPOc, SYNPOa and SYNPOb (figure 3.3). Overexpression constructs were 
cloned for SYNPOb and SYNPOc and transfected to HeLa cells, revealing that the band 
observed at 130 kDa corresponds to SYNPOc whereas SYNPOb was identified to be the 
band at 100 kDa (figure 3.4). The 110 kDa SYNPO band which seems to be podocyte 
specific is therefore most likely the SYNPOa isoform which is in compliance with the 
literature concerning the number of amino acids SYNPOa is composed of (Asanuma et 
al. 2005). In order to avoid confusion, it is of note that in many publications SYNPOa is 
referred to as SYNPO long. Migration behavior of SYNPO in HeLa cells differs from the 
predicted molecular mass by the Uniprot database, and cannot be directly compared to 
previously published data from podocytes (Mundel et al. 1997, Asanuma et al. 2005). 
Therefore it cannot be conclusively said that SYNPOa has a size of 110 kDa in HeLa 
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cells as it has in podocytes. SYNPOa is only 26 amino acids shorter than SYNPOc 
(figure 3.3) and therefore might also migrate at 130 kDa like SYNPOc in SDS-gels of 
HeLa crude extracts. Thus, the endogenous 130 kDa SYNPO band was designated as 
SYNPOa/c in this work. 
siRNA mediated knockdown of SYNPO in HeLa cells led to a loss of detectable signal for 
SYNPOa/c (130 kDa) and SYNPOb (100 kDa) (figure 3.5). In the context of the 
experiments to validate the observed SYNPO signals BAG3 protein was also analyzed. 
The siRNA mediated knockdown of SYNPO does not show any obvious effects on BAG3 
protein levels (figure 3.5). Additionally SYNPOb overexpression in HeLa cells renders 
detectable BAG3 protein levels unchanged in comparison to the control. However, there 
is a stabilization of BAG3 protein upon overexpression of SYNPOc (figure 3.4). Here it 
would be of interest whether this stabilization is due to an increase of BAG3 transcription, 
a stabilizing effect of SYNPOc on native BAG3 protein, or a consequence of an inhibitory 
effect of SYNPOc on BAG3 degradation. A transcriptional effect of SYNPOc on BAG3 
would be rather interesting in regards of a cellular stress response, as BAG3 is up-
regulated under cellular stress such as oxidative or mechanical stress (Bonelli et al. 
2004, Ulbricht et al. 2015). Upon administration of the proteasome inhibiting and 
autophagy inducing agent MG132, BAG3 is known to be up-regulated on the 
transcriptional level (Wang et al. 2008). A qPCR experiment with oligonucleotides 
specific for BAG3 gene products could give insight whether SYNPOc has an effect on 
BAG3 expression and thereby is a potential inducer of a cellular stress response via 
BAG3. 
Concerning SYNPO turnover in podocytes, it is cleaved by the lysosomal endopeptidase 
Cathepsin L (CatL). Binding to 14-3-3 protects SYNPO from this proteolytic cleavage 
(Faul et al. 2008). Treatment of HeLa cells with E64d, a specific inhibitor of CatL, did not 
show any effect on SYNPOc expression as shown in figure 3.6. Again no band at 44 kDa 
could be observed for the DMSO treated control and full length SYNPOa/c levels remain 
unchanged upon treatment with E64d. This shows that CatL mediated cleavage is likely 
to be a podocyte specific mechanism, which emphasizes, that expression and 
processing of SYNPO is highly dependent on the cell type or on the specific extracellular 
environment the cells have to face. Podocytes for example mark the outermost cover of 
the glomerular basement membrane, where they are constantly exposed to fluid shear 
stress and tensile forces arising from intravascular pressure (Vasmant et al. 1984; 
Suleiman et al. 2017). 
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To further analyze SYNPO degradation, HeLa cells were treated with either MG132, a 
proteasome inhibitor known to induce autophagy (Ding et al. 2007, Lan et al. 2014), 
BafA1 (an inhibitor of autophagy by prevention of autophagosome – lysosome fusion 
(Mauvezin et al. 2015) or with both inhibitors, followed by quantification of SYNPO 
protein via Western Blot (figure 3.7). Degradation, or a possible involvement of SYNPO 
in the proteasomal degradation pathway or autophagy would manifest itself in a 
stabilization of SYNPO upon inhibition of the respective pathway. After treatment with the 
inhibitors there is neither a stabilization nor a decrease in SYNPO protein levels 
observable (figure 3.7). Except when both inhibitors are applied SYNPOa/c levels are 
slightly diminished. This however might be due to extreme cellular stress evoked by the 
combination of both inhibitors which might induce apoptosis.  
In summary, these data demonstrate that SYNPO is stable in HeLa cells. It might be 
possible that degraded SYNPO is rapidly replaced by newly synthesized SYNPO. An 
experimental setup using the inhibitors MG132 and BafA1 in addition to an agent which 
inhibits protein translation (e.g. cyclohexamide) could give further insight into SYNPO 
turnover. 
Even though SYNPO levels remain stable upon MG132 treatment of HeLa cells, there is 
a prominent change in 130 kDa SYNPO (SYNPOa/c) upon MG132 treatment observable 
(figure 3.8). The lower band of the usual double band of 130 kDa SYNPO undergoes an 
upward shift resulting in enrichment of the upper SYNPO band. Since total amounts of 
detectable SYNPOa/c remain the same (figure 3.8) the lower band of SYNPOa/c is not 
degraded but changed in its size. Variations in migration behaviour are commonly a sign 
of post-translational modifications of a protein such as phosphorylation (Wegener et al. 
1984; Ishida et al. 2000), glycosylation (Nielsen et al. 2004) ubiquitination (Elsasser et al. 
2012) and others (Carruthers et al. 2015). Furthermore SYNPOb has been previously 
reported to be phosphorylated in vivo (Faul et al. 2008). To test whether 130 kDa 
SYNPO is also phosphorylated, HeLa cell crude extracts were subjected to lambda-
phosphatase treatment resulting in vast reduction of the upper 130 kDa SYNPO band in 
the DMSO treated control extract as well as in the MG132 treated one (figure 3.8). To 
assess the functionality of the phosphatase treatment a specific antibody against the 
phosphorylated form of the translational regulator S6 kinase 1 (S6) was used as a 
control. As for the upper band of 130 kDa SYNPO, phosphorylated S6 is largely reduced 
upon lambda-phosphatase treatment. Faul et al. (2008) identified two phosphorylation 
sites in human SYNPOb, T216 and S619. As SYNPOb shares its complete sequence 
with SYNPOa and SYNPOc (figure 3.3), SYNPOa and c contain the same potential 
phosphorylation sites. It would be of interest, whether SYNPOa and c are phosphorylated 
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at the same amino acids as SYNPOb (which would be T460 and S863 for SYNPOc 
respectively). Alanine substitution of the potential phosphor-acceptor sites of a SYNPOc 
overexpression construct would abrogate 130 kDa SYNPO phosphorylation if indeed the 
same amino acids as reported for SYNPOb are phosphorylated in SYNPOc. 
 
 
4.2 The interplay of BAG3 and SYNPO 
SYNPOa/c are the most abundantly expressed SYNPO isoforms in HeLa cells (figure 
3.3). Furthermore SYNPOa/c are the only SYNPO isoforms which co-precipitate with 
BAG3 under endogenous conditions (figure 3.1). Using an overexpression construct of 
BAG3 including a FLAG-Tag for immunoprecipitation experiments, SYNPOb can be 
observed to co-precipitate with BAG3, however to a far lesser extent than SYNPOa/c 
(figure 3.10). Additionally overexpression of SYNPOc did show a stabilizing effect on 
BAG3 (figure 3.4) and it could be shown that 130 kDa SYNPO (SYNPOa/c) is 
phosphorylated in vivo (figure 3.8). Hence, this work focussed on the further investigation 
of SYNPOc and its role as an interactor of BAG3.  
Overexpression of BAG3 in HeLa cells could stabilize SYNPOa/c protein levels (figure 
3.9, A). As described for overexpression of SYNPOc (see above) it remains unclear, 
whether this stabilization of SYNPOa/c occurs due to a translational effect or because 
BAG3 prevents SYNPOa/c degradation. As siRNA mediated knockdown of BAG3 did not 
show a significant reduction nor stabilization of SYNPOa/c protein levels (figure 3.9, B) a 
translational effect of BAG3 on SYNPOa/c seems to be favorable in this context. A qRT-
PCR experiment using specific oligonucleotides for SYNPOc mRNA would give insight 
into SYNPOc transcription upon BAG3 overexpression. Such an experiment was indeed 
performed, however primer design specific for SYNPOc mRNA and the other SYNPO 
isoforms turned out to be quite challenging as SYNPO contains, depending on the 
isoform, only one or two coding exons (data obtained from the ensemble database 
(http://www.ensembl.org)) limiting the possibilities to design oligonucleotides greatly. The 
oligonucleotides designed for this work failed to amplify the SYNPOc gene product and 
could therefore not be used. 
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4.3 BAG3 and SYNPO in CASA 
As established in figure 3.1 130 kDa SYNPO (SYNPOa/c) is a novel interactor of the co-
chaperone BAG3. The SYNPO family member SYNPO2 was previously shown to bind to 
the BAG3 WW-domain via its PPXY motif (Ulbricht et al. 2013). SYNPOc protein with 
mutant PPXY motifs was overexpressed in HeLa cells and used in immunoprecipitation 
experiments. The same was done for a WW-domain mutant of BAG3. Mutated SYNPOc 
(both PPXY motifs) as well as mutated BAG3 failed to co-precipitate BAG3 or SYNPO 
respectively, confirming that this interaction is mediated via the WW-domain of BAG3 
and SYNPO PPXY motifs (figure 3.10 and 3.11). Here the second of the two SYNPOc 
PPXY motifs seems to be of higher importance for binding BAG3 as mutation of only the 
first PPXY motif does not show any influence on BAG3 binding whereas mutation of only 
the second PPXY motif shows a vast reduction of co-precipitated BAG3. However only a 
double mutation of both PPXY motifs almost completely abrogates BAG3 binding (figure 
3.10). These data coincide with the peptide screen preformed for the identification of 
novel binding partners of the BAG3 WW-domain. Besides showing an interaction with 
SYNPO and SYNPO2 the peptide screen could narrow down the consensus binding 
motif of the BAG3 WW-domain to PP P/S Y (PhD thesis Ulbricht, 2013). The first PPXY 
motif of SYNPO contains the amino acids PPTY whereas the second motif consists of 
the amino acids PPSY. 
Previous studies have linked SYNPO2 to the BAG3 and HSC70 mediated autophagic 
degradation process of filamin in muscle and immune cells (CASA) (figure 1.5) (Ulbricht 
et al. 2013). Belonging to the same protein family and both having the ability to bind to 
BAG3, SYNPO might have similar functions as SYNPO2 in CASA but a different tissue 
specificity. However, as discussed above, treatment of HeLa cells with MG132 or BafA1 
did not show stabilization nor degradation of SYNPO (figure 3.7). This indicates that 
SYNPO behaves differently than SYNPO2, which is rapidly degraded after treatment of 
A7r5 cells with MG132 and roughly 4-fold stabilized by administration of BafA1 (Ulbricht 
et al. 2013). To further elucidate a potential link to autophagic degradation, 
immunofluorescent co-staining experiments were performed in HeLa cells using specific 
antibodies against p62 and LC3, which are both established markers for 
autophagosomes (Bjorkoy et al. 2009, Tanida et al. 2008), and LAMP1 a lysosomal 
marker (reviewed by Saftig and Klumperman, 2009; Eskelinen, 2006). If SYNPO were to 
be degraded via the autophagy lysosomal pathway a partial co-localization of SYNPO 
with these markers is expected. However all three marker proteins failed to show a co-
localization with SYNPOc punctae (figure 3.13). Together these data lead to the 
conclusion, that in regards of an involvement in CASA, SYNPO fails to conduct a similar 
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function in HeLa cells, under the experimental conditions used, as SYNPO2 does in 
muscle cells. However, as BAG3 expression is induced under cellular stress conditions, 
degradation pathways involving BAG3, like CASA, are also in dependency of cellular 
stress. For filamin degradation cellular stress is induced by mechanical strain (Ulbricht et 
al. 2013). Another protein which involves BAG3 for its degradation is the microtubule-
associated protein tau, which is primarily expressed in neurons. Tau is especially known 
for its pathological relevance in Alzheimer disease (Iqbal et al. 2010). Under stressful 
conditions, such as proteasome inhibition, BAG3 was shown to facilitate the clearance of 
soluble tau (Lei et al. 2015). In addition, BAG3 has been described to promote 
degradation of mutant huntingtin, associating BAG3 with polyQ diseases such as 
Huntington disease (Carra et al. 2008). Furthermore, Crippa et al. (2010) and 
Gamerdinger et al. (2011) describe BAG3 in degradation of amytrophic-lateral-sclerosis 
(ALS) linked mutant SOD1. It might be possible, that the chosen growth conditions for 
HeLa cells in this work do not create a cellular stress situation in which BAG3 mediated 
protein degradation is needed. Challenging of the cells by e.g. overexpressing polyQ 
constructs or starvation would generate a context in which BAG3 mediated degradation 
is “switched on”, possibly showing an effect on SYNPO behavior in HeLa cells. Here it 
would be of interest to compare SYNPO behavior to SYNPO2 in order to draw definite 
conclusions about a role of SYNPO – BAG3 interaction in autophagic degradation. 
An upstream involvement of SYNPO in CASA can also not be excluded. Due to its ability 
to bind to BAG3, SYNPO might be involved in recruitment of BAG3 to the actin 
cytoskeleton. Indeed, overexpression of SYNPOc in HeLa cells leads to the 
accumulation of BAG3 in almost the same punctate pattern as SYNPOc (figure 3.11) 
allowing for the postulation of a recruitment of BAG3 into those SYNPOc punctae and 
thereby to the actin cytoskeleton. The actin cytoskeleton has been shown to be critical for 
autophagosome formation. Upon actin depolymerization via for example cytochalasin D, 
autophagosome formation is inhibited, showing that the actin cytoskeleton is an 
important factor in autophagy (Aplin et al. 1992, Aguilera et al. 2012). It could be shown 
that actin filaments co-localize with early omegasomes prior to their association with LC3 
(Aguilera et al. 2012). Omegasomes are membrane protrusions that eventually develop 
into phagophors or isolation membranes (Axe et al. 2008). Even though the actin 
cytoskeleton is involved in the formation of autophagosomes beyond this initial step 
(reviewed by Kruppa et al. 2016), the early omegasome stage represents a possible 
timeframe in which BAG3 could be recruited by SYNPO. This is because the early 
omegasome is not yet associated with LC3, which is important because SYNPOc did not 
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co-localize with LC3 in immunofluorescence experiments (figure 3.13), making an 
involvement of SYNPO in later stages of autophagosome formation unlikely.  
 
 
4.4 SYNPO punctae: Hubs for actin polymerization? 
SYNPO has been repeatedly confirmed to be an actin binding protein (Mundel et al. 
1997, Kreemerskothen et al. 2005, Asanuma et al. 2005). Overexpression of SYNPOc in 
HeLa cells shows the previously in neuronal and kidney cells described punctate pattern 
of SYNPO in immunofluorescence experiments (figure 3.12) (Mundel et al. 1997, 
Asanuma et al. 2005). In this work a co-localization of SYNPOc punctae with phalloidin, a 
marker for the actin cytoskeleton could be observed (figure 3.13) in agreement with 
published data (Mundel et al. 1997, Asanuma et al 2005, Kremerskothen et al. 2005, 
Faul et al. 2008). In contrast to Asanuma et al. (2005) describing SYNPO punctae in 
podocytes as amorphous, cytoplasmic, phalloidin-positive aggregates, in this work 
SYNPOc punctae induced by overexpression of SYNPOc in HeLa cells appear to be 
round in shape with many of them showing small pointed protrusions rather resembling 
α-actinin-4 staining as shown by Asanuma et al. (2005) as sites of short branched actin 
filaments (figure 3.12). Furthermore, Asanuma et al. (2005) could show that co-
expression of SYNPOb and α-actinin-4 abrogates SYNPOb punctae and results in long 
parallel and unbranched actin bundles. This gives rise to the hypothesis that SYNPOc 
punctae might serve as a hub for actin polymerization in HeLa cells. This is supported by 
the ability of SYNPO to interact with BAG3. Findings by Fontanella et al. (2010) 
associate BAG3 with the eukaryotic chaperonin CCT / TRiC (cytosolic chaperonin 
containing TCP-1 / TCP-1 ring complex) suggesting a role of BAG3 in CCT substrate 
folding. This is of interest, because CCT is mandatory for the folding of actin und tubulin 
into their respective three dimensional structures (Sternlicht et al. 1993, Llorca et al. 
2000). Knockdown of CCT results in reduction of the availability of native G-actin, growth 
arrest and changes in cellular shape and motility due to alterations in tubulin and actin 
cytoskeleton integrity (Grantham et al. 2006). In the context of SYNPOc punctae and 
their potential role in actin polymerization, it might be possible that through the interaction 
of SYNPOc and BAG3, also CCT is recruited to the SYNPOc punctae creating a source 
of newly synthesized G-actin in close proximity to the polymerizing actin filaments. 
Furthermore CCT has been implicated not only in the folding of actin but also in 
regulating actin polymerization kinetics. Here CCT subunits have been shown to reduce 
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actin filament elongation in vitro suggesting a role of CCT subunits in quality control of 
the newly synthesized actin filament. However, it is more likely that CCT subunits protect 
the growing end of the actin filament as hydrophobic surfaces of the actin monomers 
building the filament are transiently exposed in the process of integration of new actin 
monomers for elongation (Grantham et al. 2002). Co-staining of SYNPOc and CCT in 
immunofluorescence experiments could give first hints on a possible connection of 
SYNPOc and BAG3 regulated actin dynamics with CCT. 
Upon overexpression of SYNPOc many rather large BAG3 positive SYNPOc punctae are 
detectable, which all might be possible sites for actin polymerization (figure 3.11). That 
few stress fibers are observable upon SYNPOc overexpression might be due to the 
excess of SYNPOc created by overexpression (figure 3.11, 3.12 and 3.13). As described 
by Asanuma et al. (2005) only co-expression of α-actinin-4 induced the formation of long 
parallel actin fibers in podocytes. Maybe the increased amount of SYNPOc can’t be 
compensated for by the endogenous α-actinin-4 levels, leaving sites of accumulated 
SYNPOc and BAG3 ready for actin polymerization but lacking an equal amount of 
required co-factors for this process. 
 
 
4.5 SYNPO interactors: hints for intracellular transport 
Via immunoprecipitation with subsequent SDS-Page, SYNPO protein complexes could 
be isolated for analysis via mass spectrometry. Many interesting potential SYNPO 
binding partners could be identified, of which many are actin cytoskeleton associated 
proteins (table 3.1). One of the binding partners identified is Annexin A2 (ANXA2). A 
FLAG-tagged overexpression construct of ANXA2 could successfully co-precipitate 130 
kDa SYNPOa/c in immunoprecipitation (figure 3.17), validating the results gained from 
mass spectrometry. Interestingly BAG3 could also be identified to co-precipitate in a 
complex with ANXA2 (figure 3.17). ANXA2 belongs to the large family (more than 160 
family members) of Annexins which are known to bind to phospholipids in a Ca2+ 
dependent manner (reviewed by Gerke and Moss, 2002). ANXA2 is specifically of 
interest as an interactor of the BAG3 – SYNPO complex as it has been described to be 
able to bind F-actin (Filipenko and Waisman, 2001). However it is reported, that ANXA2 
does not localize to stress fibers but is associated with the organization of membrane 
associated actin, especially in membrane regions enriched in sphingolipids and 
cholesterol, termed lipid rafts (Harder et al. 1997; Babiychuk and Draeger, 2000). 
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Furthermore ANXA2 is implicated in endosome biogenesis as it associates with early 
endosomal membranes and is involved in early-to-late endosomal transport via selective 
actin nucleation and polymerization (Emans et al. 1993; Mayran et al. 2003; Morel et al. 
2009). Indeed the actin cytoskeleton is, next to the microtubule cytoskeleton, a major 
player in intracellular transport of diverse cargo e.g. secretory vesicles, cellular 
organelles or protein complexes (reviewed by Ross et al. 2008). Transport is either 
mediated via polarized actin polymerization on the surface of organelles (e.g. 
micropinocytotic vesicles or pathogenic bacteria) propelling the respective cargo forward 
on so called actin comet tails (Theriot et al. 1992; Christien et al. 1999, Merrifield et al. 
2001; Orth et al. 2001). Or by motor protein dependent actin transport via proteins of the 
myosin family, which can move along actin filaments in an ATP dependent manner 
(reviewed by Hammer and Sellers (2011), Maravillas-Montero and Santos-Argumedo 
(2012)). Even more intriguingly, cargo transported on actin cytoskeletal tracks can be 
handed over to dynein or kinesin (which are the microtubule associated motor proteins) 
for further transport via the microtubule cytoskeleton and vice versa (Kural et al. 2007, 
Watanabe and Higuchi 2007). Additionally, the transported cargo can be switched from 
one actin filament to another at filament intersections (Snider et al. 2004). As SYNPO 
has been shown to be able to bind myosin II (Kannan et al. 2015) it might also be able to 
bind other myosin family members like myosin V, VI or X, which are associated with 
cargo transport (reviewed by Ross et al. 2008). 
BAG3 has also been reported to be involved in intracellular transport as a factor in 
aggresome formation via the microtubule cytoskeleton (Gamerdinger et al. 2011). 
Aggresomes are defined as microtubule-dependent, cytoplasmic inclusion bodies serving 
as a site for accumulation and sequestration of misfolded / aggregated proteins which 
can be cleared via autophagy (Johnston et al. 1998, García-Mata 1999). The 
intermediate filament protein vimentin (Herrmann and Aebi 2000) could be established as 
a marker for aggresomes as it forms a cage like structure around these perinuclear 
compartments whereas in the absence of an aggresome it is evenly distributed in the 
cytoplasm (Johnston et al. 1998). It is of note, that vimentin could also be identified as an 
interactor of SYNPO via mass spectrometry (table 3.1). Even though immunofluorescent 
staining did not show a co-localization of SYNPOc and vimentin (figure 3.13), the binding 
of the two proteins could be confirmed by immunoprecipitation (figure 3.17). 
In the context of cellular transport, BAG3 mediates loading of misfolded cargo proteins to 
the microtubule motor protein dynein through a direct interaction. The dynein – BAG3 – 
cargo complex is then transported to the aggresome (Gamerdinger et al. 2011). BAG3 
mediated cargo loading is facilitated by 14-3-3 protein which recruits BAG3 – cargo 
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complexes to the motor (Xu et al. 2013). Additionally, BAG3 mediated aggresome 
targeting of the mutant protein SOD1 via dynein is an ubiquitin independent process 
(Gamerdinger et al. 2011) in contrast to the ubiquitin-dependent mechanisms of 
aggresome targeting via dynein and Histone Deacetylase 6 (HDAC6) (Kawaguchi et al. 
2003, Ouyang et al. 2012). 
Here a potential interplay of ANXA2 with SYNPO and BAG3 could come into play by 
mediating intracellular transport along actin filaments ultimately handing over cargo to the 
microtubule network via BAG3. Through the interaction of ANXA2 – BAG3 – SYNPO – 
myosin and the actin cytoskeleton a transport machinery for e.g. endosomes may be 
generated. Here ANXA2 could mediate binding to the endosomal membrane anchoring it 
to the actin cytoskeleton via SYNPO. SYNPO in turn binds to the myosin motor and 
recruits BAG3 into the complex. For further transport along the microtubule cytoskeleton 
BAG3 could potentially mediate the switch to the dynein motor as it can bind directly to it 
and thereby releasing SYNPO, as SYNPOc does not associate with microtubuli (figure 
3.13). ANXA2 possibly remains in the BAG3 – dynein complex to mediate continued 
binding to the transported endosome. 
Indeed a co-localization of SYNPOc punctae with the early endosome marker EEA1 
could be observed in immunofluorescence (figure 3.15), underscoring a potential 
involvement of SYNPO, BAG3 and ANXA2 in endosomal trafficking. An additional 
immunofluorescence experiment using a marker for late endosomal compartments like 
Rab7 (McCaffrey et al. 2001) could further confirm the hypothesis, that SYNPO is only 
involved in trafficking of early endosomes, whereas BAG3 mediates further transport to 
late endosomal compartments. Whether the co-localization of SYNPOc with early 
endosomes indeed serves the purpose of endosomal transport could be monitored via 
life cell imaging using fluorescently labeled dextran which is taken up by endosomes and 
can thus be monitored under the microscope in combination with overexpression of 
fluorescently labeled SYNPOc. Furthermore it has to be established whether SYNPO can 
interact with the myosin motors as it can with myosin II (Kannan et al. 2015) to make 
transport along the actin cytoskeleton possible. 
Another quite exciting hypothesis in the context of early endosome transport potentially 
mediated by an interplay of BAG3 – SYNPO – ANXA2 is the delivery of membranes for 
autophagosome formation via transport of ATG9A (autophagy related 9A) positive 
endosomes. Multiple compartments are thought to serve as a resource of membranes for 
autophagosome formation such as the endoplasmic reticulum, the Golgi, the plasma 
membrane, mitochondria or early and recycling endosomes. (Ylä-Anttila et al. 2009, Yen 
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et al. 2010, Hailey et al. 2010, Ravikumar et al. 2010, Longatti and Tooze 2012, Ge et al. 
2013) ANXA2 has been associated with sorting of the transmembrane protein ATG9A 
from endosomes. Here ATG9A is taken up from the plasma membrane by endocytosis 
and is delivered to the recycling endosome via early endosomal compartments in an 
ANXA2 dependent manner (Puri et al. 2013 and 2014, Moreau et al. 2015). Eventually, 
ATG9A containing vesicles are incorporated into the autophagosomal outer membrane 
(Yamamoto et al. 2012). Upon starvation induced autophagy ANXA2 levels were 
observed to be upregulated which resulted in an increase in ATG9A vesicle movement 
and an increase in autophagosome formation (Moreau et al. 2015). Via interacting with 
ANXA2 (figure 3.17) and SYNPO association to early endosomes (figure 3.15) the BAG3 
– SYNPO complex might also be involved in this process of ATG9A containing 
membrane delivivery to autophagic structures. 
The last interesting hypothesis which needs to be taken into account is endosomal 
movement by actin comet tails potentially generated by an interplay of SYNPO, BAG3 
and ANXA2. Here co-localization of SYNPOc to endosomes and the potential role of 
SYNPO and BAG3 as a hub for actin polymerization (as described above) come into play 
together with ANXA2. It has been described, that ANXA2 plays an essential role in actin-
based rocketing of macropinosomes, which are endosomal vesicles specific for the 
uptake of extracellular fluid (Merrifield et al. 2001). Co-transfection of fluorescently 
labeled SYNPOc with Lifeact, a marker to visualize F-actin (Riedl et al. 2008) and 
addition of fluorescent dextran would allow for monitoring of endosomal trafficking and its 
dependence on actin and SYNPOc. 
 
Another interactor of SYNPO identified via mass spectrometry is Tropomyosin 1 (TPM1) 
(Table 3.1). Tropomyosins make up a family which is involved in actin dynamics, cellular 
migration and suppression of tumorigenesis (Ono and Ono, 2002; Bryce et al. 2003; 
reviewed by Gunning et al. 2008). TPM1 is, next to other tropomyosins, necessary for 
stress fiber formation via a stabilizing function, whereas another tropomyosin family 
member, TPM4, has been described to recruit myosin II to stress fibers (Tojkander et al. 
2011). Furthermore it could be shown that SYNPO can rescue Tropomyosin deficiency in 
the model organism Drosophila melanogaster and human cancer cells (Wong et al. 
2012). This interaction of SYNPO with TPM1 indicates that SYNPO does not only 
mediate stress fiber formation in podocytes but also in epithelial cells. Whether BAG3 is 
also found in a complex with SYNPO and TPM1 as could be shown for ANXA2 (see 
above) remains to be analyzed. 
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3.6 BAG3 and SYNPO in mechanotransduction 
There are several reports revealing that BAG3 as well as SYNPO are mechanosensitive 
proteins (Ulbricht et al. 2013 and 2015, Mun et al. 2014, Kannan et al. 2015). This means 
they can be stimulated by, and are involved in the reaction to mechanic impulses, turning 
a mechanical signal into a biochemical one. Thus far many proteins have been identified 
to contribute to mechanotransduction, such as integrins which are components of focal 
adhesions connecting a cell to the extracellular matrix (ECM) (reviewed by Juliano et al. 
2004) or cadherins being essential for cell-cell contacts (adherens junctions) (reviewed 
by Meng and Takeichi, 2009) as well as myosin motors which are components of actin 
stress fibers (reviewed by Vincente-Manzanares et al. 2009) and many more (reviewed 
by Ingber, 2006). In the context of mechanotransduction BAG3 was not only shown to be 
essential for the degradation of denatured filamin upon tension induced mechanical 
strain (CASA) but is also involved in regulating transcription of new filamin via inhibition 
of Large Tumor Suppressor Kinase 1 (LATS1) and Angiomotin Like 1 (AMOTL1), which 
in turn release the Hippo pathway transcription factors Yes Associated Protein 1 (YAP) 
and WW Domain Containing Transcription Regulator 1 (WWTR1 or TAZ) for nuclear 
translocation (Ulbricht et al. 2013). Connecting BAG3 to the Hippo pathway is quite 
intriguing as it is one of the major signaling pathways associated with 
mechanotransduction (Dupont et al. 2011, Aragona et al. 2013). Next to its involvement 
in filamin turnover under mechanical stress, BAG3 has been described to be involved in 
cell migration and adhesion via interaction with the guanine nucleotide exchange factor 
PDZGEF2 (PDZ domain containing Guanine Nucleotide Exchange Factor 2) which 
induces activation of Rap1 (Iwasaki et al. 2010). All this suggests that BAG3 is a major 
player in mechanotransduction and potentially has additional roles in this complex 
cellular response to mechanic stimuli, besides its fundamental role in filamin turnover. 
SYNPO has first been implicated to be a mechanosensitive protein by its involvement in 
endothelial wound healing induced by laminar shear stress (Mun et al. 2014). 
Furthermore, SYNPO has been described to protect the small GTPase RhoA from 
degradation and thereby is involved in stress fiber formation (Asanuma et al. 2006). It 
can be reasoned that SYNPO is indirectly involved in YAP/TAZ signaling via RhoA, 
because RhoA and intact stress fibers are required to maintain nuclear YAP/TAZ 
localization in response to mechanical stress (Dupont et al. 2011). Additionally, recent 
work by Kannan et al. (2015) shows SYNPO to be an important factor in maturation of 
adherens junctions under mechanical stress. Here SYNPO is recruited to the maturing 
adherens junction, where in turn it is involved in the recruitment of α-actinin-4 and 
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Vinculin. While the molecular mechanism by which SYNPO is relocated to the developing 
junction remains to be elucidated, the authors could show that SYNPO and α-actinin-4 
accumulation can be experimentally induced by applying cyclic strain to the cells 
(Kannan et al. 2015). Recruitment of SYNPO to adherens junctions may potentially be 
mediated by the membrane associated protein MAGI-1 (Membrane Associated 
Guanylate Kinase Inverted 1), a junctional protein which can bind to SYNPO, β-catenin 
(a major component of adherens juctions) as well as α-actinin-4 (Dobrosotskaya and 
James 2000, Patrie et al. 2002, Stetak and Hajnal 2011). In addition to these findings 
associating SYNPO with adherens junctions, SYNPO was reported to bind to the junction 
stabilizing factor CD2 associated protein (CD2AP) (Schiwek et al. 2004, Huber et al. 
2006, Tang and Brieher, 2013). CD2AP is a scaffolding protein and a regulator of the 
actin cytoskeleton. Recent findings identify CD2AP as a linker protein of cellular junctions 
to the actin cytoskeleton (Welsch et al. 2001, Tang and Brieher 2013). These multiple 
interactions highly suggest a role of SYNPO in cellular adhesion under mechanical 
stress. Kannan et al. (2015) propose that SYNPO is able to establish a physical link 
between adherens junctions (via binding to α-actinin-4 and MAGI-1) and actin stress 
fibers potentially via CD2AP or myosin II, which could both be established as binding 
partners of SYNPO in vivo (Schiwek et al. 2004; Huber et al. 2006; Kannan et al. 2015). 
As mentioned above, SYNPO is involved in stress fiber formation via RhoA (Asanuma et 
al. 2006). Additionally it could be shown in podocytes, that binding of SYNPOb to 14-3-3β 
in a phosphorylation dependent manner protects it from proteolytic cleavage by CatL, 
which in turn maintains stress fiber formation and integrity via RhoA (Faul et al. 2008). 
Interestingly, Kannan et al. (2015) report an upward shift of SYNPO in Western blots 
upon administration of mechanical force to the cells which closely resembles the shift in 
size observed for SYNPOa/c upon MG132 treatment in this work. As proteolytic cleavage 
of SYNPOa/c by CatL could not be observed in HeLa cells (figure 3.6) MG132 induced 
phosphorylation of SYNPOa/c might resemble SYNPO modification upon mechanical 
stimuli. How proteasomal inhibition and mechanotransduction might be connected via 
phosphorylated SYNPO remains elusive. Few data linking the proteasome and the actin 
cytoskeleton are available. In dendritic spines association of the proteasome with the 
actin cytoskeleton could be shown. The authors suggest that this association is involved 
in spatial sequestration of the proteasome to allow for local remodeling of the protein 
composition (Bingol and Schuman, 2006). Furthermore, administration of MG132 to 
Saccharomyces cerevisiae was demonstrated to result in defects in cell morphology and 
actin organization (Haarer et al. 2011). However, this effect is not surprising, as many 
factors involved in cytoskeleton dynamics are degraded by the proteasome e.g. the actin 
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capping protein CapZ (Hishiya et al. 2010), RhoA (Asanuma et al. 2006), β-catenin 
(Aberle et al. 1997), or the small GTPase Rac1 in its GTP bound (active) state (Lynch et 
al. 2006). In regards of adherens junctions MG132 has been reported to be able to block 
cadherin (the main adhesion molecule in adherens junctions) endocytosis for 
degradation or recycling by a thus far unknown mechanism (Xiao et al. 2003, cadherin 
turnover reviewed by Nanes and Kowalczyk, 2012). As BAG3 is transcriptionally 
upregulated upon MG132 treatment (Wang et al. 2008) and has been implicated to be a 
regulator of cellular adhesion and migration (Iwasaki et al. 2007 and 2010), it might be 
involved in modulating adhesive strength via interaction with SYNPO. However data on 
BAG3 involvement in cellular adhesion and migration is limited to focal adhesions rather 
than adherens junctions and no direct co-localization of BAG3 with focal adhesion 
plaques could thus far be observed (Iwasaki et al. 2007). SYNPO however, has been 
observed to localize to sites of focal adhesions (Mundel et al. 1997, Asanuma et al. 
2006) which indicates that the SYNPOc punctae which are also positive for BAG3 (figure 
3.11) are unlikely to be sites of focal adhesion. Therefore it is plausible, that SYNPO 
needs to be released of its BAG3 bound state in order to localize to sites of maturing 
adherens junctions. Additionally, the phosphorylation of SYNPOa/c in HeLa cells 
observed in this work (figure 3.8) and the reported upward shift of SYNPO in MDCK cells 
by Kannan et al. (2015) might be functionally distinct from each other as SYNPO might 
conduct different roles in differing cell types. Furthermore, Kannan et al. (2015) did not 
further investigate the nature of the observed SYNPO upward shift. It might actually be 
an effect due to another post-translational modification other than phosphorylation. 
 
 
4.7 Outlook 
In this work, the broad interactome of BAG3 could be further expanded by SYNPO. 
Whereas the exact consequence of BAG3 – SYNPO interaction remains elusive, the 
many newly identified SYNPO binding partners give hints on possible scenarios like 
intracellular transport or mechanotransduction. Especially the prospect of an involvement 
in intracellular transport could be further underlined by showing that SYNPOc punctae 
co-localize with early endosomes. The molecular function behind this co-localization and 
whether BAG3 is involved as well remains to be established.  
The question of similar functions between SYNPO and SYNPO2 in the context of BAG3 
mediated protein degradation could not be completely answered. First data point to a 
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generally different role of SYNPO than SYNPO2. However follow-up experiments are 
needed, challenging the HeLa cells with stressful stimuli to further enhance BAG3 
mediated degradation. 
In addition, SYNPO could be further characterized on a molecular level, showing that in 
HeLa cells SYNPO is a stable protein under the chosen experimental conditions. 
Furthermore, SYNPO could be shown to be phosphorylated. It would be especially 
interesting to elucidate whether SYNPO – BAG3 interaction is disrupted by 
phosphorylation of SYNPO, providing a molecular switch for this interaction. Identification 
and mutation of SYNPO phosphorylation sites is indispensable in order to answer many 
open questions on the nature of SYNPO in epithelial cells and its role as an interactor of 
BAG3.  
Taken together, this work lays a fundament for the study of BAG3 – SYNPO interaction 
in epithelial cells, providing general information about SYNPO behavior in HeLa cells and 
giving ideas on how BAG3 and SYNPO might function together in the constant effort of a 
cell to adapt to its ever changing surroundings. 
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List of Abbreviations 
 
°C   Degree Centigrate 
µ   Micro 
aa   amino acid 
ABP   actin binding protein 
AMOTL1  Angiomotin Like 1 
Amp   Ampicillin 
ANXA2  Annexin A2 
BAG   Bcl-2 associated athanogene 
BSA   Bovine serum albumin 
CASA   chaperone assisted selective autophagy 
CCT   cytosolic chaperonin containing TCP-1 
CD2AP  CD2 associated protein 
DMSO   Dimethylsulfoxide 
DNA   Desoxyribonucleic acid 
dNTP   Desoxyribonucleoside triphosphate 
E. Coli   Escherichia Coli 
ECL   enhanced chemiluminescence 
EDTA   Ethylendiamine-N,N,N’,N’-Tetraacetate 
EEA1   Early endosome antigen 1 
EM   extracellular matrix 
et al.   et aliter 
exp.   exposure 
F-actin   filamentous actin 
g   Gramm 
g   gravitational constant 
G-actin  globular / monomeric actin 
GAPDH  Glycerine-aldehyde-3-phosphate-dehydrogenase 
h   hour 
HCl   acetic acid 
HDAC6  Histone Deacetylase 6 
HSP70  Heat Shock 70 kDa Protein 
HSPB8  Heat Shock Protein Family B member 8 
IF   Immunofluorescence 
IP   Immunoprecipitation 
kb   kilo bases 
kDa   kilo Dalton 
L   liter 
LATS1   Large Tumor Suppressor Kinase 1 
LB   Luria-Bertani-Medium 
LC3   Microtubule-associated protein 1A/1B-light chain 3 
M   Molar (mol/L) 
m   Milli 
MAGI-1  Membrane Associated Guanylate Kinase Inverted 1 
min   minute 
mRNA   messenger RNA 
n   nano 
OD   optical density 
p   pico 
p62   protein 62 kDa / Sequestosome 1 
PBS   phosphate buffered saline 
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PCR   polymerase chain reaction 
RNase   Ribonuclease 
RNA   Ribonucleic acid 
RT   room temperature 
SDS   sodium dodecyl sulfate 
sec   second 
SYNPO  Synaptopodin 
SYNPOc  long isoform of Synaptopodin 929 aa 
SYNPOb  short isoform of Synaptopodin 685 aa 
TAZ   WW Domain Containing Transcription Regulator 1 (WWTR1) 
TBS   Tris-bufferd saline 
TEMED  N,N,N’,N#-Tetramethylenediamine 
TRiC    TCP-1 ring complex) 
Tris   Tris (hydroxymethyl) aminomethane 
U   units 
UV   ultraviolet 
rpm   rounds per minute 
VIM   Vimentin 
YAP   Yes Associated Protein 1) 
w/o   without 
wt   wild type 
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Figure 3.4: Overexpression of SYNPOb and SYNPOc. 
Figure 3.5: Knockdown of SYNPO isoforms by specific siRNAs. 
Figure 3.6: SYNPO is not cleaved by CatL in HeLa cells. 
Figure 3.7: Inhibition of protein degradation pathways and shift in size of SYNPOa/c. 
Figure 3.8: 130 kDa SYNPOa/c is phosphorylated. 
Figure 3.9: SYNPOa/c protein levels upon alterations in BAG3 expression. 
Figure 3.10: SYNPOc – BAG3 interaction is dependent on SYNPOc PPXY motifs and 
BAG3 WW-domain. 
Figure 3.11: SYNPOc PPXY motifs are crucial for SYNPOc – BAG3 co-localization. 
Figure 3.12: SYNPOc punctae in HeLa cells. 
Figure 3.13: SYNPOc punctae in combination with various molecular markers. 
Figure 3.14: IP of SYNPO validating its interaction with actin. 
Figure 3.15: SYNPO punctae co-localize with EEA1. 
Figure 3.16: SDS-gels of SYNPO IP for mass spectrometry. 
Figure 3.17: Annexin A2 and vimentin bind SYNPO. 
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